1 |
(4s)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydropyrimidine-5-carbonitrile |
- |
- |
- |
- |
231 [1] 231 💬 |
2 |
(r)-n-(5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1h-inden-1-yl)-1-methyl-1h-pyrazole-4-carboxamide |
Pyrazole |
- |
- |
- |
058 [1] 58 💬 |
3 |
(s)-3-((3-(1-((6-(3,4-dimethoxyphenyl)pryazin-2-yl)amino)ethyl)phenyl)carbamoyl)-5-methylpridin-1-ium |
- |
- |
- |
- |
086 [1] 86 💬 |
4 |
1-(2,3,4-trimethoxybenzyl)piperazine dihydrochloride |
Piperazine |
[6] D00807 D00807, D01393 D01393, D02127 D02127, D02145 D02145, D05486 D05486, D06224 D06224 💬 |
- |
- |
058 [1] 58 💬 |
5 |
1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-[1-piperazinyl]-3-quinoline carboxylic acid |
- |
- |
- |
- |
299 [1] 299 💬 |
6 |
10 mg natura-alpha capsule |
- |
- |
- |
- |
097 [1] 97 💬 |
7 |
1500mg mesalazine pellets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
8 |
1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- |
- |
- |
- |
- |
006 [1] 6 💬 |
9 |
1[(6- allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea |
- |
- |
- |
- |
006 [1] 6 💬 |
10 |
1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- |
- |
- |
- |
- |
006 [1] 6 💬 |
11 |
1[(6- allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea |
- |
- |
- |
- |
006 [1] 6 💬 |
12 |
2 x 10 mg natura-alpha capsules |
- |
- |
- |
- |
097 [1] 97 💬 |
13 |
2% chlorhexidine solution wipes |
Chlorhexidine |
[4] D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
299 [1] 299 💬 |
14 |
2-(3,5-dichloro-phenyl)-benzoxazole-6-carboxylat |
- |
- |
- |
- |
028 [1] 28 💬 |
15 |
2-(3,5-dichloro-phenyl)-benzoxazole-6-carboxylate |
- |
- |
- |
- |
028 [1] 28 💬 |
16 |
2-[[[(2r)-1-[1-[(4-chloro-3-methylphenyl)methyl]-4- piperidinyl]-5-oxo-2-pyrrolidinyl]carbonyl]amino]- n,n,6-trimethyl-4-pyridinecarboxamide,dihydrochloride |
- |
- |
- |
- |
006 [2] 6 , 162 💬 |
17 |
250mg mesalazine pellets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
18 |
3 mg [14c]-a4250 capsule |
- |
- |
- |
- |
093 [2] 93, 297 💬 |
19 |
4% chlorhexidine gluconate liquid skin cleanser |
Chlorhexidine |
[4] D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
299 [1] 299 💬 |
20 |
4-{[(1r,2s,3s,5s,7s)-5-hydroxy-2-adamantyl]amino}-1h-pyrrolo[2,3-b]pyridine-5-carboxamide monohydrobromide |
- |
- |
- |
- |
046 [1] 46 💬 |
21 |
500mg mesalazine pellets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
22 |
6-[2-(3,4-diethoxyphenyl)thiazol-4-yl] pyridine-2-carboxylic acid |
- |
- |
- |
- |
097 [1] 97 💬 |
23 |
750mg mesalazine pellets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
24 |
95% pure ecgc capsules 200mg |
- |
- |
- |
- |
013 [1] 13 💬 |
25 |
[18f]-(e)-n-(3-iodoprop-2-enyl)-2b-carbofluoroethoxy-3b-(4'-methylphenyl)nortropane |
- |
- |
- |
- |
006 [1] 6 💬 |
26 |
Aav9-cag-coh-sgsh |
- |
- |
- |
- |
019 [1] 19 💬 |
27 |
Acalabrutinib |
Acalabrutinib |
[1] D10893 D10893 💬 |
BTK [1] BTK 💬 |
B cell receptor signaling pathway [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency |
046 [2] 46, 61 💬 |
28 |
Acamprosate |
Acamprosate |
[2] D02780 D02780, D07058 D07058 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 [2] 6 , 206 💬 |
29 |
Accordion pill carbidopa/levodopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
30 |
Accordion pill ¿ carbidopa/levodopa 50/400 mg |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
31 |
Accordion pill ¿ carbidopa/levodopa 50/500 mg |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
32 |
Accordion pill? carbidopa/levodopa 50/400 mg |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
33 |
Accordion pill? carbidopa/levodopa 50/500 mg |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
34 |
Accordion pill™ carbidopa/levodopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
35 |
Accordion pill™ carbidopa/levodopa 50/400 mg |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
36 |
Accordion pill™ carbidopa/levodopa 50/500 mg |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
37 |
Acetyl- l- carnitine |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
265 [1] 265 💬 |
38 |
Acetyl-l-carnitine |
Acetylcarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
298 [1] 298 💬 |
39 |
Acetyl-l-carnitine 1000mg 2x per day for 3 months |
Acetylcarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
298 [1] 298 💬 |
40 |
Acz885 150 mg (canakinumab) |
Canakinumab |
[1] D09315 D09315 💬 |
IL1B [1] IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications [42] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
107 [1] 107 💬 |
41 |
Advagraf prolonged-release hard capsules |
- |
- |
- |
- |
299 [1] 299 💬 |
42 |
Ag011 - capsules |
- |
- |
- |
- |
097 [1] 97 💬 |
43 |
Alemtuzumab |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [16] 13, 15, 19, 20, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬 |
44 |
Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994 |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
046 [1] 46 💬 |
45 |
Alemtuzumab (already received by alemtuzumab cohort between 1991 and 1994) |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
046 [1] 46 💬 |
46 |
Alemtuzumab (campath ) |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
060 [1] 60 💬 |
47 |
Alemtuzumab (campath) |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
015 [1] 15 💬 |
48 |
Alemtuzumab (gz402673) |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [1] 13 💬 |
49 |
Alemtuzumab 0.2 mg |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
065 [2] 65, 164 💬 |
50 |
Alemtuzumab 0.3 mg |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
065 [2] 65, 164 💬 |
51 |
Alemtuzumab 12 mg |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [1] 13 💬 |
52 |
Alemtuzumab 24 mg |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [1] 13 💬 |
53 |
Alemtuzumab and rituximab |
Alemtuzumab |
[2] D02802 D02802, D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
060 [1] 60 💬 |
54 |
Alemtuzumab gz402673 |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [1] 13 💬 |
55 |
Alemtuzumab immunotherapy |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [1] 13 💬 |
56 |
Alemtuzumab injection |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [1] 13 💬 |
57 |
Alemtuzumab injection [lemtrada] |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
013 [1] 13 💬 |
58 |
Alemtuzumab, rituximab |
Alemtuzumab |
[2] D02802 D02802, D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
063 [1] 63 💬 |
59 |
Alentuzumab (campath) |
- |
- |
- |
- |
065 [1] 65 💬 |
60 |
Alks 8700 delayed release (dr) capsule |
- |
- |
- |
- |
013 [1] 13 💬 |
61 |
Allogeneic cardiosphere-derived cells (cap-1002) |
CAP-1002 |
- |
- |
- |
113 [1] 113 💬 |
62 |
Allogeneic human cardiosphere-derived stem cells |
- |
- |
- |
- |
086 [1] 86 💬 |
63 |
Alpha-lipoic acid and l-acetyl carnitine |
Levocarnitine |
[5] D00048 D00048, D00086 D00086, D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
005 [1] 5 💬 |
64 |
Alprostadil |
Alprostadil |
[2] D00180 D00180, D02705 D02705 💬 |
PTGER1 [1] PTGER1 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer |
051 [2] 51, 70 💬 |
65 |
Amantadine hcl extended release capsule |
Amantadine |
[2] D00777 D00777, D07441 D07441 💬 |
GRIN1 [5] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
006 [1] 6 💬 |
66 |
Ambrisentan plus spironolactone |
Ambrisentan |
[2] D00443 D00443, D07077 D07077 💬 |
EDNRA [2] EDNRA, NR3C2 💬 |
Aldosterone-regulated sodium reabsorption [8] Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
67 |
Amorphous calcium carbonate |
Calcium |
[2] D00932 D00932, D10802 D10802 💬 |
- |
- |
235 [1] 235 💬 |
68 |
Anhydrous carbidopa |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
69 |
Anti-(human tumor necrosis factor) immunoglobulin g (human-mouse monoclonal ca2 heavy chain) |
- |
- |
- |
- |
271 [1] 271 💬 |
70 |
Anti-cd19-car-t cells |
- |
- |
- |
- |
049 [1] 49 💬 |
71 |
Anti-von willebrand factor nanobody, caplacizumab |
Caplacizumab |
[1] D11160 D11160 💬 |
VWF [1] VWF 💬 |
Complement and coagulation cascades [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 [1] 64 💬 |
72 |
Anti-von willebrand factor nanobody, inn = caplacizumab |
Caplacizumab |
[1] D11160 D11160 💬 |
VWF [1] VWF 💬 |
Complement and coagulation cascades [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 [1] 64 💬 |
73 |
Antigen-specific t cells cart/ctl and dcvac |
- |
- |
- |
- |
034 [1] 34 💬 |
74 |
Antimicrobial therapy: co-trimoxazole or doxycycline |
Doxycycline |
[5] D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
085 [1] 85 💬 |
75 |
Antioxidant plus pregabalin |
Pregabalin |
[1] D02716 D02716 💬 |
CACNA2D1 [4] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 |
Adrenergic signaling in cardiomyocytes [7] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway |
298 [1] 298 💬 |
76 |
Apriso 0.375g er cap |
- |
- |
- |
- |
097 [1] 97 💬 |
77 |
Apriso 375 mg extended-release capsules |
- |
- |
- |
- |
097 [1] 97 💬 |
78 |
Arimoclomol (hard gelatine capsule) |
Arimoclomol |
[3] D00115 D00115, D06892 D06892, D11374 D11374 💬 |
- |
- |
019 [1] 19 💬 |
79 |
Arimoclomol (hpmc capsule) |
Arimoclomol |
[1] D11374 D11374 💬 |
- |
- |
019 [1] 19 💬 |
80 |
Ascal(r) / carbasalate calcium |
Calcium |
[1] D03385 D03385 💬 |
- |
- |
046 [1] 46 💬 |
81 |
Asp015k hydrobromide, as1940150-br, jkt-201a, 4-{[(1r,2s,3s,5s,7s)-5-hydroxy-2-adamantyl]amino}-1h-pyrrolo[2,3-b]pyridine-5-carboxamide monohydrobromide |
- |
- |
- |
- |
046 [1] 46 💬 |
82 |
Aspirin 650mg oral capsule |
Acetylsalicylic acid |
[1] D00109 D00109 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
83 |
At2221 65 mg formulated capsules |
- |
- |
- |
- |
256 [1] 256 💬 |
84 |
Atorvastatin |
Atorvastatin |
[3] D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 |
85 |
Atorvastatin 10mg |
Atorvastatin |
[3] D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
063 [1] 63 💬 |
86 |
Atorvastatin 20mg |
Atorvastatin |
[3] D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
063 [1] 63 💬 |
87 |
Atorvastatin calcium |
Atorvastatin |
[3] D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
265 [1] 265 💬 |
88 |
Atorvastatin tablet 20 mg |
Atorvastatin |
[3] D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
046 [1] 46 💬 |
89 |
Avcn583601 (3% cannabidiol cream) |
Cannabidiol |
[1] D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
036 [1] 36 💬 |
90 |
Azathioprine (aza) caps |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
096 [1] 96 💬 |
91 |
Azathioprine in case of endoscopic recurrence |
Azathioprine |
[2] D00238 D00238, D03033 D03033 💬 |
- |
- |
096 [1] 96 💬 |
92 |
Azathioprine or mesalazine |
Azathioprine |
[3] D00238 D00238, D00377 D00377, D03033 D03033 💬 |
- |
- |
096 [1] 96 💬 |
93 |
Azithromycin 250mg capsule |
Azithromycin |
[3] D02134 D02134, D06390 D06390, D07486 D07486 💬 |
- |
- |
084 [1] 84 💬 |
94 |
Aztreonam |
Aztreonam |
[2] D00240 D00240, D06558 D06558 💬 |
- |
- |
228 [2] 228, 299 💬 |
95 |
Aztreonam for inhalation (ai) |
Aztreonam |
[2] D00240 D00240, D06558 D06558 💬 |
- |
- |
299 [1] 299 💬 |
96 |
Aztreonam for inhalation solution |
Aztreonam |
[2] D00240 D00240, D06558 D06558 💬 |
- |
- |
299 [1] 299 💬 |
97 |
Aztreonam for inhalation solution (azli) |
Aztreonam |
[2] D00240 D00240, D06558 D06558 💬 |
- |
- |
299 [1] 299 💬 |
98 |
Aztreonam lysine |
Aztreonam |
[3] D00240 D00240, D02304 D02304, D06558 D06558 💬 |
- |
- |
299 [1] 299 💬 |
99 |
Aztreonam lysine for inhalation |
Aztreonam |
[3] D00240 D00240, D02304 D02304, D06558 D06558 💬 |
- |
- |
299 [1] 299 💬 |
100 |
Aztreonam lysine for inhalation (azli) |
Aztreonam |
[3] D00240 D00240, D02304 D02304, D06558 D06558 💬 |
- |
- |
228 [1] 228 💬 |
101 |
Aztreonam solución para inhalación |
Aztreonam |
[2] D00240 D00240, D06558 D06558 💬 |
- |
- |
299 [1] 299 💬 |
102 |
Bacille calmette-guerin vaccine |
- |
- |
- |
- |
013 [1] 13 💬 |
103 |
Bacille of calmette-guerin |
- |
- |
- |
- |
013 [1] 13 💬 |
104 |
Baclofen er capsules (grs) 10 mg |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
105 |
Baclofen er capsules (grs) 20 mg |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
106 |
Baclofen er capsules (grs) 30mg |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
107 |
Baclofen er capsules (grs) 40mg |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
108 |
Baclofen er capsules (grs) 50 mg |
Baclofen |
[1] D00241 D00241 💬 |
GABBR1 [2] GABBR1, GABBR2 💬 |
Estrogen signaling pathway [7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
109 |
Bardoxolone methyl capsules |
Bardoxolone |
[2] D09584 D09584, D09585 D09585 💬 |
- |
- |
066 [4] 66, 67, 86, 222 💬 |
110 |
Bardoxolone methyl oral capsule |
Bardoxolone |
[2] D09584 D09584, D09585 D09585 💬 |
- |
- |
067 [1] 67 💬 |
111 |
Behavioral: abbvie care 2.0 |
- |
- |
- |
- |
046 [4] 46, 96, 97, 271 💬 |
112 |
Behavioral: building better caregivers workshop |
- |
- |
- |
- |
006 [1] 6 💬 |
113 |
Behavioral: cannabis questionnaire |
Medical Cannabis |
- |
- |
- |
046 [2] 46, 271 💬 |
114 |
Behavioral: collaborative care (cc) |
- |
- |
- |
- |
013 [1] 13 💬 |
115 |
Behavioral: protein and calorie controlled diet |
- |
- |
- |
- |
251 [1] 251 💬 |
116 |
Behavioral: tip / impact plus care coordination |
- |
- |
- |
- |
046 [3] 46, 96, 97 💬 |
117 |
Best supportive care (bsc) |
- |
- |
- |
- |
331 [1] 331 💬 |
118 |
Beta carotene |
Beta carotene |
[1] D03101 D03101 💬 |
- |
- |
096 [1] 96 💬 |
119 |
Beta carotene from dunaliella algae |
Beta carotene |
[1] D03101 D03101 💬 |
- |
- |
096 [1] 96 💬 |
120 |
Beta-carotene |
Beta carotene |
[1] D03101 D03101 💬 |
- |
- |
013 [1] 13 💬 |
121 |
Bio-enhanced curcumin soft gelatin capsule |
Curcumin |
[2] D00115 D00115, D06892 D06892 💬 |
- |
- |
097 [1] 97 💬 |
122 |
Bis-choline tetrathiomolybdate |
Choline |
[1] D07690 D07690 💬 |
- |
- |
171 [1] 171 💬 |
123 |
Bitter candytuft fresh plant extract |
- |
- |
- |
- |
097 [1] 97 💬 |
124 |
Bms-986165 capsule |
- |
- |
- |
- |
049 [1] 49 💬 |
125 |
Boswellia serrata extract ps0201bo capsules |
Indian frankincense |
- |
- |
- |
013 [1] 13 💬 |
126 |
Bovine-calf alkaline phosphatase (biap) |
Alkaline Phosphatase |
- |
- |
- |
097 [1] 97 💬 |
127 |
Bovine-calf alkaline phosphatase biap |
Alkaline Phosphatase |
- |
- |
- |
097 [1] 97 💬 |
128 |
Break in l-carnitine treatment |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
316 [1] 316 💬 |
129 |
Budenofalk 3mg gastro-resistant capsules |
- |
- |
- |
- |
096 [1] 96 💬 |
130 |
Budesonide ( zentacort capsules 3mg ) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
096 [1] 96 💬 |
131 |
Budesonide 6 mg capsules, hard (bux-pvii prototype) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
132 |
Budesonide 6 mg prolonged-release capsule, hard (bux-pvii prototype) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
133 |
Budesonide 6 mg prolonged-release capsules, hard (bux-pvii prototype) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
134 |
Budesonide 9 mg capsules, hard (bux-pv) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
135 |
Budesonide 9 mg capsules, hard (bux-pvii prototype) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
136 |
Budesonide 9 mg prolonged-release capsule, hard (bux-pvii prototype) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
137 |
Budesonide 9 mg prolonged-release capsules, hard (bux-pvii prototype) |
Budesonide |
[1] D00246 D00246 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
138 |
C-type natriuretic peptide conjugated to multi-arm polyethylene glycol carrier through a cleavable linker |
Polyethylene glycol |
[1] D03370 D03370 💬 |
- |
- |
276 [1] 276 💬 |
139 |
Ca |
- |
- |
- |
- |
234 [1] 234 💬 |
140 |
Ca2 |
- |
- |
- |
- |
271 [1] 271 💬 |
141 |
Cabaletta |
Trehalose |
- |
- |
- |
018 [2] 18, 113 💬 |
142 |
Cabaletta for iv infusion once weekly during 24 weeks |
Trehalose |
- |
- |
- |
018 [1] 18 💬 |
143 |
Cabaser |
- |
- |
- |
- |
006 [1] 6 💬 |
144 |
Cabaseril |
- |
- |
- |
- |
006 [1] 6 💬 |
145 |
Cabaseril, 1,0 mg tablette |
- |
- |
- |
- |
006 [1] 6 💬 |
146 |
Cabaseril, 2,0 mg tablette |
- |
- |
- |
- |
006 [1] 6 💬 |
147 |
Cabergolina |
Cabergoline |
[1] D00987 D00987 💬 |
DRD2 [2] DRD2, PRL 💬 |
Alcoholism [12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
148 |
Cabergoline |
Cabergoline |
[1] D00987 D00987 💬 |
DRD2 [2] DRD2, PRL 💬 |
Alcoholism [12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
006 [3] 6 , 74, 75 💬 |
149 |
Cabergoline teva |
Cabergoline |
[1] D00987 D00987 💬 |
DRD2 [2] DRD2, PRL 💬 |
Alcoholism [12] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
075 [1] 75 💬 |
150 |
Cablivi |
- |
- |
- |
- |
064 [1] 64 💬 |
151 |
Cabozantinib |
Cabozantinib |
[1] D10062 D10062 💬 |
AXL [3] AXL, KDR, MET 💬 |
Adherens junction [24] Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Calcium signaling pathway, Central carbon metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Epithelial cell signaling in Helicobacter pylori infection, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, Hepatocellular carcinoma, MAPK signaling pathway, Malaria, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Renal cell carcinoma, Transcriptional misregulation in cancer, VEGF signaling pathway |
034 [1] 34 💬 |
152 |
Cael-101 |
- |
- |
- |
- |
028 [1] 28 💬 |
153 |
Caffeic acid tablets |
- |
- |
- |
- |
063 [1] 63 💬 |
154 |
Caffeine |
Caffeine |
[2] D00528 D00528, D01453 D01453 💬 |
ADORA1 [11] ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism [22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 [9] 2 , 6 , 13, 21, 46, 78, 96, 97, 265 💬 |
155 |
Caffeine 100 mg |
Caffeine |
[2] D00528 D00528, D01453 D01453 💬 |
ADORA1 [11] ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism [22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 [2] 96, 97 💬 |
156 |
Caffeine 100-200 mg bid |
Caffeine |
[2] D00528 D00528, D01453 D01453 💬 |
ADORA1 [11] ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism [22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
157 |
Caffeine alkaloid |
Caffeine |
[2] D00528 D00528, D01453 D01453 💬 |
ADORA1 [11] ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism [22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
158 |
Calcichew d3 forte |
- |
- |
- |
- |
113 [1] 113 💬 |
159 |
Calcichew tablets |
- |
- |
- |
- |
274 [1] 274 💬 |
160 |
Calcifediol |
Calcifediol |
[1] D00122 D00122 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
113 [1] 113 💬 |
161 |
Calcineurin inhibitors |
- |
- |
- |
- |
050 [1] 50 💬 |
162 |
Calcineurin inhibitors maintenance |
- |
- |
- |
- |
067 [1] 67 💬 |
163 |
Calcio |
Calcium |
- |
- |
- |
013 [1] 13 💬 |
164 |
Calcio folinato dc.it |
Calcium |
- |
- |
- |
013 [1] 13 💬 |
165 |
Calcipotriene |
Calcipotriol |
[1] D01125 D01125 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
051 [1] 51 💬 |
166 |
Calcipotriol |
Calcipotriol |
[1] D01125 D01125 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
036 [1] 36 💬 |
167 |
Calcitonin |
- |
- |
- |
- |
225 [1] 225 💬 |
168 |
Calcitonin (salmon) |
Salmon, unspecified |
- |
- |
- |
225 [1] 225 💬 |
169 |
Calcitonin nasal spray (salmon) |
Salmon, unspecified |
- |
- |
- |
096 [2] 96, 97 💬 |
170 |
Calcitriol |
Calcitriol |
[1] D00129 D00129 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
037 [8] 37, 46, 49, 66, 96, 158, 235, 326 💬 |
171 |
Calcitriol & calcium |
Calcitriol |
[1] D00129 D00129 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
235 [1] 235 💬 |
172 |
Calcium |
Calcium |
- |
- |
- |
006 [27] 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
173 |
Calcium and cholecalciferol |
Calcium |
[1] D00188 D00188 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
046 [1] 46 💬 |
174 |
Calcium and vitamin d combination |
Calcium |
- |
- |
- |
013 [1] 13 💬 |
175 |
Calcium carbonate |
Calcium |
[2] D00932 D00932, D10802 D10802 💬 |
- |
- |
013 [8] 13, 19, 46, 53, 75, 96, 235, 299 💬 |
176 |
Calcium carbonate and alphacalcidol |
Calcium |
[2] D00932 D00932, D10802 D10802 💬 |
- |
- |
235 [1] 235 💬 |
177 |
Calcium carbonate d |
Calcium |
[2] D00932 D00932, D10802 D10802 💬 |
- |
- |
053 [1] 53 💬 |
178 |
Calcium channel blockers |
Calcium |
- |
- |
- |
051 [1] 51 💬 |
179 |
Calcium citrate |
Calcium |
[1] D00933 D00933 💬 |
- |
- |
046 [3] 46, 84, 235 💬 |
180 |
Calcium citrate with vitamin d2 |
Calcium |
[2] D00187 D00187, D00933 D00933 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
084 [1] 84 💬 |
181 |
Calcium gluconate |
Calcium |
[1] D00935 D00935 💬 |
- |
- |
214 [3] 214, 215, 235 💬 |
182 |
Calcium lactate |
Calcium |
[2] D00936 D00936, D02254 D02254 💬 |
- |
- |
235 [1] 235 💬 |
183 |
Calcium levofolinate |
Calcium |
- |
- |
- |
013 [1] 13 💬 |
184 |
Calcium rosuvastatin |
Calcium |
[2] D01915 D01915, D08492 D08492 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
079 [1] 79 💬 |
185 |
Calcium, dietary |
Calcium |
- |
- |
- |
298 [1] 298 💬 |
186 |
Cald hr-d (high-risk, regimen c) |
- |
- |
- |
- |
019 [5] 19, 20, 125, 234, 326 💬 |
187 |
Cald hr-d (high-risk, regimen d) |
- |
- |
- |
- |
019 [5] 19, 20, 125, 234, 326 💬 |
188 |
Cald sr-a (standard-risk, regimen a) |
- |
- |
- |
- |
019 [5] 19, 20, 125, 234, 326 💬 |
189 |
Cald sr-b (standard-risk, regimen b) |
- |
- |
- |
- |
019 [5] 19, 20, 125, 234, 326 💬 |
190 |
Calfactant |
Calfactant |
[1] D03317 D03317 💬 |
- |
- |
299 [1] 299 💬 |
191 |
Calogen |
- |
- |
- |
- |
002 [1] 2 💬 |
192 |
Caltrate pill |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
193 |
Calvan® 100 mg |
- |
- |
- |
- |
008 [1] 8 💬 |
194 |
Caly-002 |
- |
- |
- |
- |
098 [1] 98 💬 |
195 |
Cam-3001 |
Mavrilimumab |
[1] D09930 D09930 💬 |
CSF2RA [1] CSF2RA 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
046 [1] 46 💬 |
196 |
Cam2043 |
- |
- |
- |
- |
051 [1] 51 💬 |
197 |
Campath |
- |
- |
- |
- |
019 [12] 19, 20, 49, 51, 60, 62, 65, 164, 234, 283, 285, 326 💬 |
198 |
Campath -1h |
- |
- |
- |
- |
065 [1] 65 💬 |
199 |
Campath 1h |
- |
- |
- |
- |
060 [4] 60, 65, 164, 285 💬 |
200 |
Campath, busulfan, clofarabine |
Busulfan |
[2] D00248 D00248, D03546 D03546 💬 |
POLA1 [3] POLA1, POLA2, RRM1 💬 |
DNA replication [6] DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
326 [1] 326 💬 |
201 |
Campath, chemo and/or tbi allo sct |
- |
- |
- |
- |
060 [3] 60, 62, 283 💬 |
202 |
Campath, fludarabine, cyclophosphamide |
Cyclophosphamide |
[4] D00287 D00287, D01907 D01907, D07760 D07760, D07966 D07966 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
065 [2] 65, 284 💬 |
203 |
Campath-1h |
- |
- |
- |
- |
019 [6] 19, 20, 60, 234, 285, 326 💬 |
204 |
Campath-1h (alemtuzumab) |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
060 [1] 60 💬 |
205 |
Canakinumab |
Canakinumab |
[1] D09315 D09315 💬 |
IL1B [1] IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications [42] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
046 [10] 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 💬 |
206 |
Canakinumab (acz885) |
Canakinumab |
[1] D09315 D09315 💬 |
IL1B [1] IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications [42] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
106 [1] 106 💬 |
207 |
Canakinumab (company code: acz885d) |
Canakinumab |
[1] D09315 D09315 💬 |
IL1B [1] IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications [42] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
106 [1] 106 💬 |
208 |
Canakinumab (investigational) |
Canakinumab |
[1] D09315 D09315 💬 |
IL1B [1] IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications [42] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
046 [1] 46 💬 |
209 |
Canakinumab (proposed) |
Canakinumab |
[1] D09315 D09315 💬 |
IL1B [1] IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications [42] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
046 [1] 46 💬 |
210 |
Canakinumab (who approval pending) |
Canakinumab |
[1] D09315 D09315 💬 |
IL1B [1] IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications [42] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
106 [1] 106 💬 |
211 |
Canakinumab injection [ilaris] |
Canakinumab |
[1] D09315 D09315 💬 |
IL1B [1] IL1B 💬 |
AGE-RAGE signaling pathway in diabetic complications [42] AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alzheimer disease, Amoebiasis, Antifolate resistance, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection |
113 [1] 113 💬 |
212 |
Candesartan |
Candesartan |
[1] D00522 D00522 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
058 [2] 58, 67 💬 |
213 |
Candesartan and cilnidipine |
Candesartan |
[2] D00522 D00522, D01173 D01173 💬 |
AGTR1 [6] AGTR1, CACNA1B, CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
AGE-RAGE signaling pathway in diabetic complications [48] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Apelin signaling pathway, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prion disease, Renin secretion, Renin-angiotensin system, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
067 [1] 67 💬 |
214 |
Candesartan plus non-ccb agents |
Candesartan |
[1] D00522 D00522 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
067 [1] 67 💬 |
215 |
Cannabidiol |
Cannabidiol |
[1] D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
006 [17] 6 , 8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 226, 271 💬 |
216 |
Cannabidiol (cbd) |
Cannabidiol |
[1] D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
006 [6] 6 , 140, 144, 145, 156, 158 💬 |
217 |
Cannabidiol , synthetic form |
Cannabidiol |
[1] D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
096 [1] 96 💬 |
218 |
Cannabidiol / dronabinol capsule 5 mg+2,5 mg |
Cannabidiol |
[2] D00306 D00306, D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 [1] 13 💬 |
219 |
Cannabidiol botanical drug substance (cbd bds) |
Cannabidiol |
[1] D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 [1] 13 💬 |
220 |
Cannabidiol capsule 5 mg |
Cannabidiol |
[1] D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 [1] 13 💬 |
221 |
Cannabidiol oral solution |
Cannabidiol |
[1] D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
140 [4] 140, 144, 145, 193 💬 |
222 |
Cannabidiol tablet 10 mg |
Cannabidiol |
[1] D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
046 [2] 46, 271 💬 |
223 |
Cannabidiol vaginal suppository |
Cannabidiol |
[1] D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
226 [1] 226 💬 |
224 |
Cannabis |
Medical Cannabis |
- |
- |
- |
002 [8] 2 , 6 , 13, 46, 90, 96, 97, 271 💬 |
225 |
Cannabis based medicine extract (sativex) |
Medical Cannabis |
- |
- |
- |
013 [1] 13 💬 |
226 |
Cannabis oil |
Medical Cannabis |
- |
- |
- |
006 [1] 6 💬 |
227 |
Cannabis sativa extract oromucosal spray |
Medical Cannabis |
- |
- |
- |
002 [1] 2 💬 |
228 |
Cannabis, medical |
Medical Cannabis |
- |
- |
- |
002 [5] 2 , 6 , 13, 96, 97 💬 |
229 |
Cannador |
- |
- |
- |
- |
013 [1] 13 💬 |
230 |
Cap-1002 |
CAP-1002 |
- |
- |
- |
113 [1] 113 💬 |
231 |
Capecitabine |
Capecitabine |
[1] D01223 D01223 💬 |
TYMS [1] TYMS 💬 |
Antifolate resistance [4] Antifolate resistance, Metabolic pathways, One carbon pool by folate, Pyrimidine metabolism |
094 [1] 94 💬 |
232 |
Capillarema |
- |
- |
- |
- |
051 [1] 51 💬 |
233 |
Caplacizumab |
Caplacizumab |
[1] D11160 D11160 💬 |
VWF [1] VWF 💬 |
Complement and coagulation cascades [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 [1] 64 💬 |
234 |
Caplacizumab (alx-0081) |
Caplacizumab |
[1] D11160 D11160 💬 |
VWF [1] VWF 💬 |
Complement and coagulation cascades [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 [1] 64 💬 |
235 |
Caplacizumab (an anti-von willebrand factor nanobody alx-0081) |
Caplacizumab |
[1] D11160 D11160 💬 |
VWF [1] VWF 💬 |
Complement and coagulation cascades [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 [1] 64 💬 |
236 |
Caplacizumab (an anti-von willebrand factor nanobody) |
Caplacizumab |
[1] D11160 D11160 💬 |
VWF [1] VWF 💬 |
Complement and coagulation cascades [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 [1] 64 💬 |
237 |
Caprylic triglyceride |
Tricaprylin |
- |
- |
- |
013 [1] 13 💬 |
238 |
Capsaicin |
Capsaicin |
[1] D00250 D00250 💬 |
TRPV1 [1] TRPV1 💬 |
Inflammatory mediator regulation of TRP channels [2] Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
002 [5] 2 , 6 , 19, 86, 226 💬 |
239 |
Capsaicin challenge |
Capsaicin |
[1] D00250 D00250 💬 |
TRPV1 [1] TRPV1 💬 |
Inflammatory mediator regulation of TRP channels [2] Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
002 [1] 2 💬 |
240 |
Capsaicin vapor |
Capsaicin |
[1] D00250 D00250 💬 |
TRPV1 [1] TRPV1 💬 |
Inflammatory mediator regulation of TRP channels [2] Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
006 [1] 6 💬 |
241 |
Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg) |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
242 |
Capsules with 160 mg teavigo (at least 94% egcg) |
Epigallocatechin gallate |
- |
- |
- |
013 [1] 13 💬 |
243 |
Captopril |
Captopril |
[1] D00251 D00251 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
017 [2] 17, 86 💬 |
244 |
Capture |
Bifenthrin |
- |
- |
- |
006 [2] 6 , 46 💬 |
245 |
Carbaglu |
- |
- |
- |
- |
245 [2] 245, 246 💬 |
246 |
Carbamazepine |
Carbamazepine |
[1] D00252 D00252 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 [2] 13, 231 💬 |
247 |
Carbasalate calcium |
Calcium |
[1] D03385 D03385 💬 |
- |
- |
046 [1] 46 💬 |
248 |
Carbetocin |
Carbetocin |
[1] D07229 D07229 💬 |
OXTR [1] OXTR 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
193 [1] 193 💬 |
249 |
Carbidopa |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 [9] 2 , 4 , 6 , 13, 17, 90, 140, 164, 201 💬 |
250 |
Carbidopa (fu) |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
251 |
Carbidopa 20 mg |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
252 |
Carbidopa 200mg oral dose |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [2] 6 , 17 💬 |
253 |
Carbidopa 27.5 mg |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
254 |
Carbidopa 65 mg capsule |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
255 |
Carbidopa and levodopa 25mg/100mg |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
256 |
Carbidopa and levodopa tablets, usp |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
257 |
Carbidopa anidra |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
258 |
Carbidopa fu |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
259 |
Carbidopa inn |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
260 |
Carbidopa levodopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
261 |
Carbidopa monohydrate |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
262 |
Carbidopa, levodopa, entacapone |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
263 |
Carbidopa- levodopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
264 |
Carbidopa-4'-monophosphate |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
265 |
Carbidopa-levodopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
002 [3] 2 , 4 , 6 💬 |
266 |
Carbidopa-levodopa 25 mg-100 mg oral tablet |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
267 |
Carbidopa/l-dopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
268 |
Carbidopa/l-dopa/entacapone |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
269 |
Carbidopa/levodopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
270 |
Carbidopa/levodopa, immediate release |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
271 |
Carbidopa/levodopa/entacapone |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
272 |
Carbidopamonohydraat |
- |
- |
- |
- |
006 [1] 6 💬 |
273 |
Carbodopa levadopa |
- |
- |
- |
- |
006 [1] 6 💬 |
274 |
Carbodopa/levadopa |
- |
- |
- |
- |
006 [1] 6 💬 |
275 |
Carbohydrates intake |
- |
- |
- |
- |
257 [1] 257 💬 |
276 |
Carbolithium |
- |
- |
- |
- |
002 [1] 2 💬 |
277 |
Carbolithium*100cps 150mg |
- |
- |
- |
- |
002 [1] 2 💬 |
278 |
Carbomer |
Carbomer |
- |
- |
- |
053 [1] 53 💬 |
279 |
Carbomer 974p |
Carbomer |
- |
- |
- |
053 [1] 53 💬 |
280 |
Carbon |
Activated charcoal |
[1] D03251 D03251 💬 |
- |
- |
006 [9] 6 , 46, 50, 51, 85, 86, 96, 97, 298 💬 |
281 |
Carbon dioxide |
Activated charcoal |
[2] D00004 D00004, D03251 D03251 💬 |
- |
- |
050 [3] 50, 51, 97 💬 |
282 |
Carbon monoxide |
Activated charcoal |
[2] D03251 D03251, D09706 D09706 💬 |
- |
- |
085 [3] 85, 86, 298 💬 |
283 |
Carbonate |
Carbonate ion |
- |
- |
- |
002 [12] 2 , 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬 |
284 |
Carbonate de lithium |
Carbonate ion |
- |
- |
- |
002 [1] 2 💬 |
285 |
Carboplatin |
Carboplatin |
[1] D01363 D01363 💬 |
- |
- |
028 [4] 28, 34, 60, 85 💬 |
286 |
Carboxymethylcellulose |
Carboxymethylcellulose |
[1] D07622 D07622 💬 |
- |
- |
035 [2] 35, 162 💬 |
287 |
Cardicor |
- |
- |
- |
- |
113 [1] 113 💬 |
288 |
Cardicor (merck brand) |
- |
- |
- |
- |
113 [1] 113 💬 |
289 |
Cardiovascular profile |
- |
- |
- |
- |
113 [1] 113 💬 |
290 |
Cardura |
- |
- |
- |
- |
067 [1] 67 💬 |
291 |
Care as usual |
- |
- |
- |
- |
015 [1] 15 💬 |
292 |
Carfilzomib |
Carfilzomib |
[1] D08880 D08880 💬 |
PSMB5 [1] PSMB5 💬 |
Alzheimer disease [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
028 [1] 28 💬 |
293 |
Carglumic acid |
Carglumic acid |
[1] D07130 D07130 💬 |
CPS1 [1] CPS1 💬 |
Alanine, aspartate and glutamate metabolism [6] Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Biosynthesis of amino acids, Carbon metabolism, Metabolic pathways, Nitrogen metabolism |
245 [3] 245, 246, 251 💬 |
294 |
Carglumic acid (carbaglu®) |
Carglumic acid |
[1] D07130 D07130 💬 |
CPS1 [1] CPS1 💬 |
Alanine, aspartate and glutamate metabolism [6] Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Biosynthesis of amino acids, Carbon metabolism, Metabolic pathways, Nitrogen metabolism |
245 [2] 245, 246 💬 |
295 |
Carisbamate |
Carisbamate |
[1] D06573 D06573 💬 |
- |
- |
144 [1] 144 💬 |
296 |
Carmustine |
Carmustine |
[1] D00254 D00254 💬 |
- |
- |
011 [5] 11, 13, 14, 28, 60 💬 |
297 |
Carmustine, etoposide, cytarabine, and melphalan (beam) |
Carmustine |
[7] D00125 D00125, D00168 D00168, D00254 D00254, D00369 D00369, D03046 D03046, D03637 D03637, D04107 D04107 💬 |
TOP2A [2] TOP2A, TOP2B 💬 |
Platinum drug resistance [1] Platinum drug resistance |
013 [1] 13 💬 |
298 |
Carnitine |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
005 [8] 5 , 13, 58, 96, 97, 265, 298, 316 💬 |
299 |
Carnosine |
Carnosine |
- |
- |
- |
006 [2] 6 , 13 💬 |
300 |
Carnosine supplementation |
Carnosine |
- |
- |
- |
006 [1] 6 💬 |
301 |
Carnosine, capsulle, 2 g/day, 8 weeks |
Carnosine |
- |
- |
- |
013 [1] 13 💬 |
302 |
Carrageenan |
- |
- |
- |
- |
097 [1] 97 💬 |
303 |
Carvedilol |
Carvedilol |
[2] D00255 D00255, D03415 D03415 💬 |
ADRA1A [5] ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 |
AMPK signaling pathway [12] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [5] 6 , 57, 86, 113, 210 💬 |
304 |
Carvi extractum fluidum |
- |
- |
- |
- |
097 [1] 97 💬 |
305 |
Cas # in d.3.9.1 for sodium salt. cas number 1639325-43-1 (parent acid) |
- |
- |
- |
- |
254 [1] 254 💬 |
306 |
Cas name: 1,4-benzoxazepin-5(2h)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4- (trifluoromethoxy)phenyl] iupac name: 4-(pyrimidin-2-ylmethyl)-7-[4- (trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2h)-one |
- |
- |
- |
- |
058 [1] 58 💬 |
307 |
Cas name: 1,4-benzoxazepin-5(2h)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4-(trifluoromethoxy)phenyl] iupac name: 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2h)-one |
- |
- |
- |
- |
058 [1] 58 💬 |
308 |
Cas no.: 7758-16-9 |
- |
- |
- |
- |
166 [1] 166 💬 |
309 |
Cas# in d.3.9.1 for sodium salt. cas number 1639325-43-1 (parent acid) |
- |
- |
- |
- |
254 [1] 254 💬 |
310 |
Casein |
Casein |
- |
- |
- |
097 [1] 97 💬 |
311 |
Casein glycomacropeptide (cgmp) |
Casein |
- |
- |
- |
097 [1] 97 💬 |
312 |
Casimersen |
Casimersen |
[1] D11988 D11988 💬 |
DMD [1] DMD 💬 |
Arrhythmogenic right ventricular cardiomyopathy [4] Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, Viral myocarditis |
113 [1] 113 💬 |
313 |
Caspofungin |
Caspofungin |
[2] D02501 D02501, D07626 D07626 💬 |
- |
- |
060 [1] 60 💬 |
314 |
Caspofungin acetate |
Acetate |
[2] D02501 D02501, D07626 D07626 💬 |
- |
- |
060 [1] 60 💬 |
315 |
Cat-1004 |
- |
- |
- |
- |
113 [1] 113 💬 |
316 |
Cat-354 |
- |
- |
- |
- |
097 [1] 97 💬 |
317 |
Catapres ampoules |
- |
- |
- |
- |
006 [1] 6 💬 |
318 |
Catapresan |
- |
- |
- |
- |
078 [1] 78 💬 |
319 |
Catapressan |
- |
- |
- |
- |
006 [1] 6 💬 |
320 |
Cathepsin s |
- |
- |
- |
- |
053 [1] 53 💬 |
321 |
Cathepsin s inhibitor |
- |
- |
- |
- |
053 [1] 53 💬 |
322 |
Catridecacog |
Catridecacog |
[1] D10532 D10532 💬 |
- |
- |
097 [2] 97, 288 💬 |
323 |
Caudal epidural injection |
- |
- |
- |
- |
070 [1] 70 💬 |
324 |
Caudal epidural injection with celestone |
- |
- |
- |
- |
070 [1] 70 💬 |
325 |
Caudal epidural injection with depomedrol |
- |
- |
- |
- |
070 [1] 70 💬 |
326 |
Caudal epidural injection with generic celestone |
- |
- |
- |
- |
070 [1] 70 💬 |
327 |
Caveolin-1-scaffolding-protein-derived peptide (lti-03) |
- |
- |
- |
- |
085 [1] 85 💬 |
328 |
Cavosonstat |
Cavosonstat |
[1] D10916 D10916 💬 |
- |
- |
299 [1] 299 💬 |
329 |
Cayston |
- |
- |
- |
- |
299 [1] 299 💬 |
330 |
Cayston 75 mg pulver und lösungsmittel zur herstellung einer lösung für einen vernebler |
- |
- |
- |
- |
299 [1] 299 💬 |
331 |
Cayston aztreonam 75 mg powder and solvent for nebuliser solution |
Aztreonam |
[2] D00240 D00240, D06558 D06558 💬 |
- |
- |
299 [1] 299 💬 |
332 |
Ceftazidime |
Ceftazidime |
[2] D00921 D00921, D07654 D07654 💬 |
- |
- |
299 [1] 299 💬 |
333 |
Ceftazidime and tobramycin |
Ceftazidime |
[4] D00063 D00063, D00921 D00921, D02542 D02542, D07654 D07654 💬 |
- |
- |
299 [1] 299 💬 |
334 |
Ceftazidime pentahydrate |
Ceftazidime |
[2] D00921 D00921, D07654 D07654 💬 |
- |
- |
299 [1] 299 💬 |
335 |
Ceftazidime/avibactam |
Avibactam |
[2] D00921 D00921, D07654 D07654 💬 |
- |
- |
299 [1] 299 💬 |
336 |
Celebrex 200 mg capsule, hard |
- |
- |
- |
- |
046 [1] 46 💬 |
337 |
Celebrex 200mg capsule |
- |
- |
- |
- |
070 [1] 70 💬 |
338 |
Celecoxib 200mg capsule |
Celecoxib |
[1] D00567 D00567 💬 |
PTGS2 [1] PTGS2 💬 |
Alzheimer disease [22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [1] 46 💬 |
339 |
Chlorhexidine |
Chlorhexidine |
[4] D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
086 [2] 86, 299 💬 |
340 |
Chlorhexidine gluconate |
Chlorhexidine |
[4] D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
299 [1] 299 💬 |
341 |
Chlorhexidine gluconate oral rinse |
Chlorhexidine |
[4] D00858 D00858, D01345 D01345, D03463 D03463, D07668 D07668 💬 |
- |
- |
299 [1] 299 💬 |
342 |
Choline |
Choline |
[1] D07690 D07690 💬 |
- |
- |
093 [4] 93, 171, 193, 299 💬 |
343 |
Choline chloride |
Chloride ion |
[1] D07690 D07690 💬 |
- |
- |
299 [1] 299 💬 |
344 |
Choline supplementation |
Choline |
[1] D07690 D07690 💬 |
- |
- |
299 [1] 299 💬 |
345 |
Ck-3773274 - granules in capsule |
- |
- |
- |
- |
058 [1] 58 💬 |
346 |
Clonidine |
Clonidine |
[2] D00281 D00281, D00604 D00604 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
006 [2] 6 , 78 💬 |
347 |
Clonidine hcl cf 0,150 mg, tabletten |
Clonidine |
[2] D00281 D00281, D00604 D00604 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
078 [1] 78 💬 |
348 |
Clonidine hydrochloride |
Clonidine |
[2] D00281 D00281, D00604 D00604 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
006 [2] 6 , 78 💬 |
349 |
Cobamamide |
Cobamamide |
[1] D00042 D00042 💬 |
- |
- |
299 [1] 299 💬 |
350 |
Cofactor supplementation (thiamine, riboflavin, l-carnitine) |
Levocarnitine |
[7] D00050 D00050, D01622 D01622, D01913 D01913, D02030 D02030, D02176 D02176, D04713 D04713, D08580 D08580 💬 |
- |
- |
265 [1] 265 💬 |
351 |
Cohort 1:nilotinib oral capsules (150mg or 300mg) |
Nilotinib |
[1] D08953 D08953 💬 |
ABL1 [4] ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia [32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 [1] 6 💬 |
352 |
Cohort 2: nilotinib oral capsules (dose to be determined from cohort 1) |
Nilotinib |
[1] D08953 D08953 💬 |
ABL1 [4] ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia [32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 [1] 6 💬 |
353 |
Colchicine sprinkle capsules |
Colchicine |
[1] D00570 D00570 💬 |
TUBB [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬 |
Alzheimer disease [10] Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection |
266 [1] 266 💬 |
354 |
Combination product: l-dopa 70mg/carbidopa 7mg |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
355 |
Comparator: carbidopa |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
356 |
Comparator: diclofenac |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [1] 46 💬 |
357 |
Comparator: diclofenac sodium |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [1] 46 💬 |
358 |
Compound thrombosis capsule sig: 1.5g/tid |
- |
- |
- |
- |
090 [1] 90 💬 |
359 |
Continuous infusion ceftazidime |
Ceftazidime |
[2] D00921 D00921, D07654 D07654 💬 |
- |
- |
299 [1] 299 💬 |
360 |
Continuous intrajejunal infusion of levodopa-carbidopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
361 |
Controlled-release levodopa / carbidopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
362 |
Corn oil capsules |
Corn |
- |
- |
- |
046 [1] 46 💬 |
363 |
Cphc (carboxy pyrrolidine hexanoyl pyrrolidone carboxylate) |
- |
- |
- |
- |
028 [1] 28 💬 |
364 |
Creon 10000 capsules |
- |
- |
- |
- |
299 [1] 299 💬 |
365 |
Crestor tablets (calcium rosuvastatin) film-coated tablets |
Calcium |
[2] D01915 D01915, D08492 D08492 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
079 [1] 79 💬 |
366 |
Crystalline calcium supplements |
Calcium |
- |
- |
- |
235 [1] 235 💬 |
367 |
Cyclo ((diaminoethyl-carbamate)hypro-phg-(d) trp-ly di-aspartate |
- |
- |
- |
- |
075 [1] 75 💬 |
368 |
Cyclo ((diaminoethyl-carbamate)hypro-phg-(d)trp-ly di-aspartate |
- |
- |
- |
- |
075 [1] 75 💬 |
369 |
Cyclo((diaminoethyl-carbamate)hypro-phg-(d)trp-lys-tyr(bzl)-phe) di-aspartate |
- |
- |
- |
- |
075 [1] 75 💬 |
370 |
Cyclo(diaminoethyl-carbamate)hypro-phg-(d)trp-lys-tyr(bzl)-phe) |
- |
- |
- |
- |
075 [1] 75 💬 |
371 |
Cyclophosphamide,campath ih and tbi |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
060 [1] 60 💬 |
372 |
Cystagon (cysteamine bitartrate) immediate-release capsules |
Cysteamine |
[2] D03634 D03634, D03635 D03635 💬 |
- |
- |
299 [1] 299 💬 |
373 |
Cysteamine bitartrate delayed-release capsules |
Cysteamine |
[2] D03634 D03634, D03635 D03635 💬 |
- |
- |
019 [1] 19 💬 |
374 |
Cysteamine bitartrate delayed-release capsules (rp103) |
Cysteamine |
[2] D03634 D03634, D03635 D03635 💬 |
- |
- |
019 [1] 19 💬 |
375 |
D9421-c capsule 3 mg |
- |
- |
- |
- |
096 [1] 96 💬 |
376 |
Delayed and extended release mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
377 |
Delayed release 6mp or calcitriol vs. purinethol |
Calcitriol |
[1] D00129 D00129 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 [1] 96 💬 |
378 |
Delta-9-tetrahydrocannabinol (thc) and cannabidiol (cbd) |
Cannabidiol |
[2] D00306 D00306, D10915 D10915 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
008 [1] 8 💬 |
379 |
Device: air filled balloon catheter |
- |
- |
- |
- |
051 [1] 51 💬 |
380 |
Device: cadd-legacy ambulatory infusion pump |
- |
- |
- |
- |
006 [1] 6 💬 |
381 |
Device: cadd-legacy® 1400 ambulatory infusion pump |
- |
- |
- |
- |
006 [1] 6 💬 |
382 |
Device: capacity of muscular oxygen extraction |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
013 [1] 13 💬 |
383 |
Device: capsule endoscopy |
- |
- |
- |
- |
096 [1] 96 💬 |
384 |
Device: carbon fiber ankle foot orthosis (afo) |
Activated charcoal |
[1] D03251 D03251 💬 |
- |
- |
006 [1] 6 💬 |
385 |
Device: carbon modular radial head |
Activated charcoal |
[1] D03251 D03251 💬 |
- |
- |
046 [1] 46 💬 |
386 |
Device: carbon modular radial head replacement |
Activated charcoal |
[1] D03251 D03251 💬 |
- |
- |
046 [1] 46 💬 |
387 |
Device: carboxymethylcellulose with ionic silver (aquacel ag) |
Carboxymethylcellulose |
[1] D07622 D07622 💬 |
- |
- |
035 [2] 35, 162 💬 |
388 |
Device: clonidine (catapressan) |
Clonidine |
[2] D00281 D00281, D00604 D00604 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
006 [1] 6 💬 |
389 |
Device: four-point cane (fpc) |
- |
- |
- |
- |
013 [1] 13 💬 |
390 |
Device: fractional carbon dioxide laser |
Activated charcoal |
[2] D00004 D00004, D03251 D03251 💬 |
- |
- |
051 [1] 51 💬 |
391 |
Device: fractionated carbon dioxide (fco2) laser |
Activated charcoal |
[2] D00004 D00004, D03251 D03251 💬 |
- |
- |
050 [1] 50 💬 |
392 |
Device: high flow nasal oxygen cannula |
Oxygen |
[1] D00003 D00003 💬 |
- |
- |
299 [1] 299 💬 |
393 |
Device: infusion pump: cadd-legacy® 1400 pump |
- |
- |
- |
- |
006 [1] 6 💬 |
394 |
Device: insertable cardiac monitor |
Methamidophos |
- |
- |
- |
058 [1] 58 💬 |
395 |
Device: interbody cage (peek) |
- |
- |
- |
- |
070 [1] 70 💬 |
396 |
Device: interbody cage (titanium) |
Titanium |
- |
- |
- |
070 [1] 70 💬 |
397 |
Device: relizorb (immobilized lipase) cartridge |
- |
- |
- |
- |
299 [1] 299 💬 |
398 |
Device: single-point cane (spc) |
- |
- |
- |
- |
013 [1] 13 💬 |
399 |
Device: smartpill motility system & pillcam patency capsule |
- |
- |
- |
- |
299 [1] 299 💬 |
400 |
Device: solid state catheter |
- |
- |
- |
- |
051 [1] 51 💬 |
401 |
Device: therm-apptm th, thermographic camera |
- |
- |
- |
- |
070 [1] 70 💬 |
402 |
Device: titanium cage |
Titanium |
- |
- |
- |
070 [1] 70 💬 |
403 |
Device: usual care |
- |
- |
- |
- |
086 [1] 86 💬 |
404 |
Dextromethorphan and caffeine |
Caffeine |
[5] D00528 D00528, D00848 D00848, D01453 D01453, D03742 D03742, D03744 D03744 💬 |
ADORA1 [17] ADORA1, ADORA2A, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A, SIGMAR1 💬 |
Alcoholism [37] Alcoholism, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Huntington disease, Insulin signaling pathway, Long-term potentiation, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
078 [1] 78 💬 |
405 |
Dextromethorphan hbr and quinidine sulfate |
Dextromethorphan |
[7] D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 [11] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes [22] Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
002 [1] 2 💬 |
406 |
Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg |
Dextromethorphan |
[7] D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 [11] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes [22] Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
002 [2] 2 , 13 💬 |
407 |
Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg |
Dextromethorphan |
[7] D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 [11] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes [22] Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
002 [2] 2 , 13 💬 |
408 |
Dextromethorphan/quinidine |
Dextromethorphan |
[7] D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 [11] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes [22] Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
013 [1] 13 💬 |
409 |
Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg) |
Dextromethorphan |
[7] D00642 D00642, D00643 D00643, D00848 D00848, D02272 D02272, D03742 D03742, D03744 D03744, D08458 D08458 💬 |
GRIN1 [11] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A, SIGMAR1 💬 |
Adrenergic signaling in cardiomyocytes [22] Adrenergic signaling in cardiomyocytes, Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, Taste transduction, cAMP signaling pathway |
008 [1] 8 💬 |
410 |
Diagnostic test: calprotectin |
- |
- |
- |
- |
097 [1] 97 💬 |
411 |
Diagnostic test: candy glucose tolerance test |
Dextrose, unspecified form |
- |
- |
- |
299 [1] 299 💬 |
412 |
Diagnostic test: cardiac mri (gadolinium enhanced) |
Gadolinium |
- |
- |
- |
086 [1] 86 💬 |
413 |
Diagnostic test: functional residual capacity |
- |
- |
- |
- |
294 [1] 294 💬 |
414 |
Diagnostic test: iontophoresis sessions in forearm of subjects with pilocarpine |
Pilocarpine |
[3] D00525 D00525, D02200 D02200, D05478 D05478 💬 |
CHRM2 [2] CHRM2, CHRM3 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
299 [1] 299 💬 |
415 |
Diagnostic test: simultaneous combined 18f-fdg pet and cardiac mri imaging |
Fludeoxyglucose (18F) |
- |
- |
- |
084 [1] 84 💬 |
416 |
Diazoxide choline |
Choline |
[2] D00294 D00294, D07690 D07690 💬 |
ABCC8 [2] ABCC8, KCNJ11 💬 |
ABC transporters [4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
193 [1] 193 💬 |
417 |
Diazoxide choline controlled-release tablet |
Choline |
[2] D00294 D00294, D07690 D07690 💬 |
ABCC8 [2] ABCC8, KCNJ11 💬 |
ABC transporters [4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
193 [1] 193 💬 |
418 |
Diclofenac |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [4] 13, 34, 46, 271 💬 |
419 |
Diclofenac + omeprazole |
Diclofenac |
[7] D00455 D00455, D00903 D00903, D00904 D00904, D01207 D01207, D05259 D05259, D05261 D05261, D07816 D07816 💬 |
ATP4A [4] ATP4A, ATP4B, PTGS1, PTGS2 💬 |
Alzheimer disease [26] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Collecting duct acid secretion, Gastric acid secretion, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxidative phosphorylation, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
046 [1] 46 💬 |
420 |
Diclofenac 50 milligrams |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
271 [1] 271 💬 |
421 |
Diclofenac sodium |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
034 [2] 34, 46 💬 |
422 |
Diclofenac sodium topical gel |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
423 |
Diclofenac sr |
Diclofenac |
[3] D00903 D00903, D00904 D00904, D07816 D07816 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
271 [1] 271 💬 |
424 |
Diltiazem |
Diltiazem |
[3] D00616 D00616, D03830 D03830, D07845 D07845 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [3] 51, 58, 86 💬 |
425 |
Diltiazem gel 2% |
Diltiazem |
[3] D00616 D00616, D03830 D03830, D07845 D07845 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
051 [1] 51 💬 |
426 |
Diltiazem hydrochloride |
Diltiazem |
[3] D00616 D00616, D03830 D03830, D07845 D07845 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
427 |
Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhithmias) |
Amiodarone |
[2] D00636 D00636, D02910 D02910 💬 |
ADRA1A [16] ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway [31] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway |
028 [1] 28 💬 |
428 |
Diuretics (plus antiarrhythmic drugs, i.e. amiodarone, in case of complex ventricular arrhythmias) plus egcg |
Amiodarone |
[2] D00636 D00636, D02910 D02910 💬 |
ADRA1A [16] ADRA1A, ADRA1B, ADRA1D, ADRB1, KCND3, KCNJ11, KCNJ12, KCNJ3, KCNJ5, KCNJ8, KCNQ1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway [31] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Dilated cardiomyopathy, Dopaminergic synapse, Estrogen signaling pathway, Gap junction, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, Insulin secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Pancreatic secretion, Protein digestion and absorption, Regulation of lipolysis in adipocytes, Renin secretion, Retrograde endocannabinoid signaling, Salivary secretion, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Type II diabetes mellitus, Vascular smooth muscle contraction, Vibrio cholerae infection, cAMP signaling pathway, cGMP-PKG signaling pathway |
028 [1] 28 💬 |
429 |
Doxazosin |
Doxazosin |
[2] D00608 D00608, D07874 D07874 💬 |
ADRA1A [3] ADRA1A, ADRA1B, ADRA1D 💬 |
AMPK signaling pathway [7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
057 [2] 57, 67 💬 |
430 |
Doxycycline |
Doxycycline |
[5] D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
013 [15] 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 162, 167, 227, 280, 299 💬 |
431 |
Doxycycline 100 mg capsules |
Doxycycline |
[5] D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
089 [1] 89 💬 |
432 |
Doxycycline 100-200mg capsules daily for 6 months |
Doxycycline |
[5] D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
167 [1] 167 💬 |
433 |
Doxycycline hyclate |
Doxycycline |
[5] D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
023 [3] 23, 96, 227 💬 |
434 |
Doxycycline hyclate ph.eur |
Doxycycline |
[5] D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
167 [1] 167 💬 |
435 |
Doxycycline tablets |
Doxycycline |
[5] D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
046 [1] 46 💬 |
436 |
Dronabinol capsule 2,5 mg |
Dronabinol |
[1] D00306 D00306 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
013 [1] 13 💬 |
437 |
Dronabinol capsule 2.5. mg |
Dronabinol |
[1] D00306 D00306 💬 |
CNR1 [2] CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
046 [2] 46, 271 💬 |
438 |
Drug inducing arthritis, lupus, hepatitis, or capillary leak syndrom |
- |
- |
- |
- |
046 [2] 46, 49 💬 |
439 |
Drug-carbamazepine (tegretol xr) |
Carbamazepine |
[1] D00252 D00252 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
231 [1] 231 💬 |
440 |
Dsg3-caart |
- |
- |
- |
- |
035 [1] 35 💬 |
441 |
Duodopa, levodopa 20 mg/ml + carbidopa 5 mg/ml, intestinal gel |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
442 |
Entacapone and carbidopa |
Carbidopa |
[2] D00558 D00558, D00781 D00781 💬 |
COMT [2] COMT, DDC 💬 |
Alcoholism [10] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
443 |
Ergocalciferol |
Ergocalciferol |
[1] D00187 D00187 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
046 [5] 46, 84, 96, 97, 299 💬 |
444 |
Ergocalciferol (vitamin d2) |
Ergocalciferol |
[1] D00187 D00187 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
299 [1] 299 💬 |
445 |
Ergocalciferol 1.25 mg tablet |
Ergocalciferol |
[1] D00187 D00187 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
046 [1] 46 💬 |
446 |
Ethylhydrogenfumarat, calciumsalz |
- |
- |
- |
- |
049 [1] 49 💬 |
447 |
Fbs0701 capsule |
- |
- |
- |
- |
284 [1] 284 💬 |
448 |
Fecal microbiota capsule |
- |
- |
- |
- |
097 [1] 97 💬 |
449 |
Fengshigutong capsule |
- |
- |
- |
- |
271 [1] 271 💬 |
450 |
Fengshigutong capsule plus imrecoxib |
Imrecoxib |
- |
- |
- |
271 [1] 271 💬 |
451 |
Ferric carboxy maltose |
Maltose |
[1] D00044 D00044 💬 |
- |
- |
096 [1] 96 💬 |
452 |
Ferric carboxymaltose |
Ferric carboxymaltose |
[1] D08920 D08920 💬 |
- |
- |
086 [4] 86, 96, 97, 299 💬 |
453 |
Filgrastim, alemtuzumab |
Alemtuzumab |
[2] D02802 D02802, D03235 D03235 💬 |
CSF3R [1] CSF3R 💬 |
Cytokine-cytokine receptor interaction [5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
065 [1] 65 💬 |
454 |
Fluocinolone acetonide |
Fluocinolone |
[1] D01825 D01825 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
090 [1] 90 💬 |
455 |
Fosfomycin |
Fosfomycin |
[4] D00925 D00925, D02187 D02187, D02188 D02188, D04253 D04253 💬 |
- |
- |
096 [2] 96, 97 💬 |
456 |
Gabapentin |
Gabapentin |
[1] D00332 D00332 💬 |
CACNA2D1 [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
006 [5] 6 , 13, 19, 70, 298 💬 |
457 |
Gabapentin prescriptions |
Gabapentin |
[1] D00332 D00332 💬 |
CACNA2D1 [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
298 [1] 298 💬 |
458 |
Gaboxadol monohydrate 0.5 mg capsule |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [1] 201 💬 |
459 |
Gaboxadol monohydrate 2 mg capsule |
Gaboxadol |
[1] D04282 D04282 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
201 [1] 201 💬 |
460 |
Gadovist 1 mmol/ml solución inyectable en jeringa precargada/ cartucho precargado |
- |
- |
- |
- |
013 [1] 13 💬 |
461 |
Gb002 capsules |
- |
- |
- |
- |
086 [1] 86 💬 |
462 |
Gbt440 300 mg capsule |
- |
- |
- |
- |
085 [1] 85 💬 |
463 |
Genetic: amplification by pcr and direct sequencing on the entire coding sequence and intron-exons boundaries of the candidate gene |
- |
- |
- |
- |
265 [1] 265 💬 |
464 |
Glpg0259 oral capsule |
- |
- |
- |
- |
046 [1] 46 💬 |
465 |
Gr181413a/at1001 capsule |
- |
- |
- |
- |
019 [1] 19 💬 |
466 |
Green tea leaf |
Green tea leaf |
[1] D06903 D06903 💬 |
- |
- |
017 [1] 17 💬 |
467 |
Gsk1605786 capsule |
- |
- |
- |
- |
096 [1] 96 💬 |
468 |
Gsk2018682 cd2 capsule |
- |
- |
- |
- |
013 [1] 13 💬 |
469 |
Harmonized supportive care |
- |
- |
- |
- |
038 [2] 38, 39 💬 |
470 |
Hcq/cq and cab combined treatment |
- |
- |
- |
- |
074 [1] 74 💬 |
471 |
Heparin 25mg inhalation powder, hard capsule |
Heparin |
[1] D07510 D07510 💬 |
SERPINC1 [1] SERPINC1 💬 |
Complement and coagulation cascades [1] Complement and coagulation cascades |
299 [1] 299 💬 |
472 |
High-caloric fatty diet |
- |
- |
- |
- |
002 [1] 2 💬 |
473 |
High-carbohdyrate breakfast |
- |
- |
- |
- |
265 [1] 265 💬 |
474 |
Hyaluronic acid |
Hyaluronic acid |
[1] D08043 D08043 💬 |
- |
- |
046 [5] 46, 53, 70, 226, 231 💬 |
475 |
Hyaluronic acid and chondroitin sulfate |
Chondroitin sulfate |
[2] D00080 D00080, D08043 D08043 💬 |
- |
- |
226 [1] 226 💬 |
476 |
Hyaluronic acid inhalation solution |
Hyaluronic acid |
[1] D08043 D08043 💬 |
- |
- |
231 [1] 231 💬 |
477 |
Hyaluronic acid/chondroitin sulfate |
Chondroitin sulfate |
[2] D00080 D00080, D08043 D08043 💬 |
- |
- |
226 [1] 226 💬 |
478 |
Hydrocortisone modified release capsules |
Hydrocortisone |
[1] D00088 D00088 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
081 [1] 81 💬 |
479 |
Hymecromone |
Hymecromone |
[1] D00170 D00170 💬 |
- |
- |
094 [1] 94 💬 |
480 |
Hyperimmune caprine serum |
- |
- |
- |
- |
051 [1] 51 💬 |
481 |
Hyperimmune caprine serum against hiv lysate |
- |
- |
- |
- |
013 [1] 13 💬 |
482 |
Ibandronate+alfacalcidol+calcium |
Alfacalcidol |
[2] D01518 D01518, D08056 D08056 💬 |
FDPS [2] FDPS, VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [8] Endocrine and other factor-regulated calcium reabsorption, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Terpenoid backbone biosynthesis, Tuberculosis |
049 [1] 49 💬 |
483 |
Ibd98-m delayed-release capsules |
- |
- |
- |
- |
097 [1] 97 💬 |
484 |
Ibuprofen |
Ibuprofen |
[4] D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [6] 13, 46, 65, 113, 271, 299 💬 |
485 |
Ibuprofen 200mg |
Ibuprofen |
[4] D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
113 [1] 113 💬 |
486 |
Ibuprofen sandoz 400 mg filmtabletten |
Ibuprofen |
[4] D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
487 |
Idl-2965 oral capsule |
- |
- |
- |
- |
085 [1] 85 💬 |
488 |
Iguratimod (careram) |
Iguratimod |
[1] D01146 D01146 💬 |
NFKB1 [1] NFKB1 💬 |
AGE-RAGE signaling pathway in diabetic complications [72] AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amoebiasis, Antifolate resistance, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease - COVID-19, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Longevity regulating pathway, MAPK signaling pathway, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway |
046 [1] 46 💬 |
489 |
Imatinib mesylate 400mg capsule |
Imatinib |
[2] D01441 D01441, D08066 D08066 💬 |
ABL1 [3] ABL1, KIT, PDGFRA 💬 |
Acute myeloid leukemia [31] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
089 [1] 89 💬 |
490 |
Immediate release carbidopa/levodopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
491 |
Immediate release carbidopa/levodopa 10/100 mg |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
492 |
Immediate release carbidopa/levodopa 25/100 mg |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
493 |
Immune globulin (human), 10% caprylate/chromatography purified |
- |
- |
- |
- |
011 [1] 11 💬 |
494 |
Immune globulin (human), 10% caprylate/chromatography purified (igiv-c) |
- |
- |
- |
- |
011 [1] 11 💬 |
495 |
Immune globulin intravenous [human], 10% caprylate/chromatography purified |
- |
- |
- |
- |
065 [1] 65 💬 |
496 |
Immune globulin iv (human), 10% caprylate/chromatography purified |
- |
- |
- |
- |
014 [1] 14 💬 |
497 |
Immune globulin iv [human], 10% caprylate/chromatography purified |
- |
- |
- |
- |
013 [1] 13 💬 |
498 |
Immune globulin subcutaneous (human), 20% caprylate/chromatography purified (igsc 20%) |
- |
- |
- |
- |
065 [1] 65 💬 |
499 |
Immune globulin subcutaneous (human), 20%, caprylate/chromatography purified |
- |
- |
- |
- |
065 [1] 65 💬 |
500 |
Imnovid 1 mg hard capsules |
- |
- |
- |
- |
051 [1] 51 💬 |
501 |
Inactive reminder capsules |
- |
- |
- |
- |
019 [1] 19 💬 |
502 |
Inhaled cannabis |
Medical Cannabis |
- |
- |
- |
013 [1] 13 💬 |
503 |
Inhaled carbon monoxide |
Activated charcoal |
[2] D03251 D03251, D09706 D09706 💬 |
- |
- |
085 [1] 85 💬 |
504 |
Interferon beta 1a, oral doxycycline |
Doxycycline |
[6] D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D04554 D04554, D07876 D07876 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
505 |
Interferon beta treatment to add-on atorvastatin treatment |
Atorvastatin |
[3] D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [1] 13 💬 |
506 |
Interferon beta-1b/atorvastatin group |
Atorvastatin |
[4] D00258 D00258, D00746 D00746, D00887 D00887, D07474 D07474 💬 |
HMGCR [3] HMGCR, IFNAR1, IFNAR2 💬 |
AMPK signaling pathway [22] AMPK signaling pathway, Bile secretion, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, Metabolic pathways, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Terpenoid backbone biosynthesis, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
507 |
Intermittent, short infusion ceftazidime |
Ceftazidime |
[2] D00921 D00921, D07654 D07654 💬 |
- |
- |
299 [1] 299 💬 |
508 |
Intranasal carbetocin dose 1 |
Carbetocin |
[1] D07229 D07229 💬 |
OXTR [1] OXTR 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
193 [1] 193 💬 |
509 |
Intranasal carbetocin dose 2 |
Carbetocin |
[1] D07229 D07229 💬 |
OXTR [1] OXTR 💬 |
Calcium signaling pathway [4] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway |
193 [1] 193 💬 |
510 |
Intravenous administration of ferric carboxymaltose |
Ferric carboxymaltose |
[1] D08920 D08920 💬 |
- |
- |
086 [1] 86 💬 |
511 |
Iodine |
Iodine |
[1] D00108 D00108 💬 |
- |
- |
046 [2] 46, 88 💬 |
512 |
Ir cd-ld (carbidopa-levodopa) tablets |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
513 |
Irbesartan 150-300mg capsules daily for 6 months |
Irbesartan |
[1] D00523 D00523 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
167 [1] 167 💬 |
514 |
Isoniazid |
Isoniazid |
[3] D00346 D00346, D01501 D01501, D02002 D02002 💬 |
- |
- |
254 [1] 254 💬 |
515 |
Isotopic intravenous [13c]-urea |
Urea |
[2] D00023 D00023, D01749 D01749 💬 |
- |
- |
251 [1] 251 💬 |
516 |
Iv ceftazidime |
Ceftazidime |
[2] D00921 D00921, D07654 D07654 💬 |
- |
- |
299 [1] 299 💬 |
517 |
Ixazomib (ninlaro®) capsules |
Ixazomib |
[1] D10130 D10130 💬 |
PSMB5 [1] PSMB5 💬 |
Alzheimer disease [8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia |
013 [1] 13 💬 |
518 |
Jkb-122 in capsule or tablet form |
- |
- |
- |
- |
095 [1] 95 💬 |
519 |
Jnj-40346527-aac - capsule - 50 mg |
JNJ-40346527 |
- |
- |
- |
046 [1] 46 💬 |
520 |
Kar5585 capsules |
- |
- |
- |
- |
086 [1] 86 💬 |
521 |
Kremezin®, spherical adsorptive carbon |
Activated charcoal |
[1] D03251 D03251 💬 |
- |
- |
096 [2] 96, 97 💬 |
522 |
Kunxian capsule |
- |
- |
- |
- |
046 [2] 46, 271 💬 |
523 |
L acetyl carnitine |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
013 [1] 13 💬 |
524 |
L-carnitine |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
013 [6] 13, 96, 97, 265, 298, 316 💬 |
525 |
Lactobacillus casei dg |
- |
- |
- |
- |
097 [1] 97 💬 |
526 |
Lactobacillus casei dg (enterolactis duo®) |
- |
- |
- |
- |
006 [1] 6 💬 |
527 |
Lactobacillus casei rhamnosus (lcr35) |
- |
- |
- |
- |
296 [1] 296 💬 |
528 |
Lantus 100 units/ml solution for injection in a cartridge |
- |
- |
- |
- |
299 [1] 299 💬 |
529 |
Lantus® 100 units/ml solution for injection in a vial. lantus® 100 units/ml solution for injection in a cartridge. lantus® 100 units/ml solution for injection in a pre-filled pen |
- |
- |
- |
- |
299 [1] 299 💬 |
530 |
Laquinimod capsulas 0.6 mg |
Laquinimod |
- |
- |
- |
013 [1] 13 💬 |
531 |
Laquinimod capsules 0.3 mg |
Laquinimod |
- |
- |
- |
013 [1] 13 💬 |
532 |
Laquinimod capsules 0.5 mg |
Laquinimod |
- |
- |
- |
008 [2] 8 , 96 💬 |
533 |
Laquinimod capsules 0.6 mg |
Laquinimod |
- |
- |
- |
013 [1] 13 💬 |
534 |
Lenabasum 20 mg powder in capsule |
- |
- |
- |
- |
051 [1] 51 💬 |
535 |
Lenabasum 5 mg powder in capsule |
- |
- |
- |
- |
051 [1] 51 💬 |
536 |
Leucovorin |
Leucovorin |
[3] D01211 D01211, D07986 D07986, D07987 D07987 💬 |
- |
- |
019 [2] 19, 46 💬 |
537 |
Levemir 100 u/ml solution for injection in a cartridge, levemir 100 u/ml solution for injection in a pre-filled pen |
- |
- |
- |
- |
299 [1] 299 💬 |
538 |
Levocarnitine |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
003 [3] 3 , 53, 97 💬 |
539 |
Levocarnitine propyl hydrochloride |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
097 [1] 97 💬 |
540 |
Levodopa (l-dopa) + standard care |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
541 |
Levodopa 100 mg a cap |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
542 |
Levodopa 125 mg a cap |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
543 |
Levodopa 150 mg a cap |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
544 |
Levodopa 75 mg a cap |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
545 |
Levodopa and carbidopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
546 |
Levodopa and carbidopa sc solution |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
547 |
Levodopa and carbidopa solution for sc administration |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
548 |
Levodopa carbidopa (lc) oral encapsulated immediate release (ir) tablets |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
549 |
Levodopa carbidopa intestinal gel (lcig) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
550 |
Levodopa, carbidopa, entacapone |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
551 |
Levodopa, carbidopa, odm-104 |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
552 |
Levodopa-carbidopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [2] 6 , 90 💬 |
553 |
Levodopa-carbidopa (lc) oral encapsulated immediate release (ir) tablets |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
554 |
Levodopa-carbidopa immediate release (lc-ir) tablets |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
555 |
Levodopa-carbidopa intestinal gel |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
556 |
Levodopa-carbidopa intestinal gel (lcig) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
557 |
Levodopa-carbidopa multilayer extended release tablet |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
558 |
Levodopa-carbidopa xl tablet (m) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
559 |
Levodopa-carbidopa-entacapone |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
560 |
Levodopa/carbidopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [2] 6 , 164 💬 |
561 |
Levodopa/carbidopa (4:1) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
201 [1] 201 💬 |
562 |
Levodopa/carbidopa (ld/cd) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
563 |
Levodopa/carbidopa (sinemet) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
564 |
Levodopa/carbidopa 100/25 |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
565 |
Levodopa/carbidopa hydrate |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
566 |
Levodopa/carbidopa solution |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
567 |
Levodopa/carbidopa(200mg/50mg) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
568 |
Levodopa/carbidopa/entacapone |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
569 |
Lisinopril, losartan, and atorvastatin |
Atorvastatin |
[7] D00258 D00258, D00357 D00357, D00362 D00362, D00887 D00887, D07474 D07474, D08131 D08131, D08146 D08146 💬 |
ACE [3] ACE, AGTR1, HMGCR 💬 |
AGE-RAGE signaling pathway in diabetic complications [22] AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Bile secretion, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
222 [1] 222 💬 |
570 |
Lithium carbonate |
Carbonate ion |
[1] D00801 D00801 💬 |
- |
- |
002 [6] 2 , 13, 17, 18, 19, 127 💬 |
571 |
Litio carbonato |
- |
- |
- |
- |
002 [2] 2 , 17 💬 |
572 |
Lojuxta 10 mg hard capsules |
- |
- |
- |
- |
079 [1] 79 💬 |
573 |
Lojuxta 20 mg hard capsules |
- |
- |
- |
- |
079 [1] 79 💬 |
574 |
Lojuxta 5 mg hard capsules |
- |
- |
- |
- |
079 [1] 79 💬 |
575 |
Lomitapide 2mg hard capsules |
Lomitapide |
[1] D09637 D09637 💬 |
MTTP [1] MTTP 💬 |
Fat digestion and absorption [1] Fat digestion and absorption |
079 [1] 79 💬 |
576 |
Losec capsules 20 mg |
- |
- |
- |
- |
046 [1] 46 💬 |
577 |
Low calorie protein substitute |
- |
- |
- |
- |
240 [1] 240 💬 |
578 |
Low carbohydrate ketogenic diet |
- |
- |
- |
- |
256 [1] 256 💬 |
579 |
Low dose cannabis |
Medical Cannabis |
- |
- |
- |
013 [1] 13 💬 |
580 |
Low molecular weight heparin calcium injection |
Calcium |
[1] D07510 D07510 💬 |
SERPINC1 [1] SERPINC1 💬 |
Complement and coagulation cascades [1] Complement and coagulation cascades |
224 [1] 224 💬 |
581 |
Lutein (10 or 30 mg/day) capsules |
Lutein |
- |
- |
- |
090 [1] 90 💬 |
582 |
Lx3305 250 mg capsule |
- |
- |
- |
- |
161 [1] 161 💬 |
583 |
Manufacturerd by cambridge therapeutic antibody centre, burroughs wellcome, glaxo wellcome) |
- |
- |
- |
- |
046 [1] 46 💬 |
584 |
Mbx-8025 10 mg capsule |
MBX-8025 |
- |
- |
- |
093 [1] 93 💬 |
585 |
Mbx-8025 2 mg capsule |
MBX-8025 |
- |
- |
- |
093 [1] 93 💬 |
586 |
Mbx-8025 5 mg capsule |
MBX-8025 |
- |
- |
- |
093 [1] 93 💬 |
587 |
Md1003 100 mg capsule |
- |
- |
- |
- |
020 [1] 20 💬 |
588 |
Md1003 100mg capsule |
- |
- |
- |
- |
013 [1] 13 💬 |
589 |
Medical standard of care for itp |
- |
- |
- |
- |
063 [1] 63 💬 |
590 |
Mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
046 [3] 46, 96, 97 💬 |
591 |
Mesalazine (3,600 mg) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
592 |
Mesalazine (asacol®) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
593 |
Mesalazine (mesalamine) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
594 |
Mesalazine - tid 1000 mg |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
595 |
Mesalazine - tid 2x 500 mg |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
596 |
Mesalazine 1000 mg gastro-resistant tablets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
597 |
Mesalazine 250mg |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
598 |
Mesalazine 250mg tablet and nitazoxanide 500mg oral tablet |
Mesalazine |
[2] D00377 D00377, D02486 D02486 💬 |
- |
- |
097 [1] 97 💬 |
599 |
Mesalazine 4g enema |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
600 |
Mesalazine 500 mg gastro-resistant tablets (salofa |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
601 |
Mesalazine 500 mg gastro-resistant tablets (salofalk® 500 mg) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
602 |
Mesalazine ec 500 mg |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
603 |
Mesalazine enema |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
604 |
Mesalazine liquid enema |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
605 |
Mesalazine slow-release granules |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
606 |
Mesalazine sustained-release tablets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
607 |
Mesalazine tablet |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
608 |
Mesalazine tablets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
609 |
Mesalazine with hydrocortisone sodium succinate |
Hydrocortisone |
[2] D00088 D00088, D00377 D00377 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
097 [1] 97 💬 |
610 |
Mesalazine, tripterygium glycosides |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
096 [1] 96 💬 |
611 |
Methotrexate capsules |
Methotrexate |
[2] D00142 D00142, D02115 D02115 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
612 |
Methotrexate, leucovorin and bms-986142 |
BMS-986142 |
[5] D00142 D00142, D01211 D01211, D02115 D02115, D07986 D07986, D07987 D07987 💬 |
DHFR [2] DHFR, DHFR2 💬 |
Antifolate resistance [5] Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 [1] 46 💬 |
613 |
Methyl 4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo [3,4-b]pyridine-3-yl]-5-pyrimidinyl(methyl)carb |
- |
- |
- |
- |
086 [2] 86, 88 💬 |
614 |
Metopirone 250 mg capsules |
- |
- |
- |
- |
075 [1] 75 💬 |
615 |
Metopirone 250 mg capsules/cormeto |
- |
- |
- |
- |
075 [1] 75 💬 |
616 |
Metoprolol succinate + doxazosin |
Doxazosin |
[5] D00601 D00601, D00608 D00608, D02358 D02358, D05011 D05011, D07874 D07874 💬 |
ADRA1A [4] ADRA1A, ADRA1B, ADRA1D, ADRB1 💬 |
AMPK signaling pathway [12] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
057 [1] 57 💬 |
617 |
Metronidazole capsule 50 mg |
Metronidazole |
[3] D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
097 [1] 97 💬 |
618 |
Mild dose cannabis |
Medical Cannabis |
- |
- |
- |
013 [1] 13 💬 |
619 |
Mirdametinib (pd-0325901) oral capsule or dispersible tablet |
PD-0325901 |
- |
- |
- |
034 [1] 34 💬 |
620 |
Mmx mesalamine/ mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
621 |
Mmx mesalamine/mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
622 |
Mmx mesalamine/mesalazine (high dose) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
623 |
Mmx mesalamine/mesalazine (low dose) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
624 |
Monoclonal antibody ca2 |
- |
- |
- |
- |
096 [1] 96 💬 |
625 |
Mtc trx0014-001 capsules |
- |
- |
- |
- |
127 [1] 127 💬 |
626 |
Multi-modal pain management [acetaminophen + gabapentin] |
Acetaminophen |
[2] D00217 D00217, D00332 D00332 💬 |
CACNA2D1 [7] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, PTGS1, PTGS2, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [31] Adrenergic signaling in cardiomyocytes, Alzheimer disease, Arachidonic acid metabolism, Arrhythmogenic right ventricular cardiomyopathy, C-type lectin receptor signaling pathway, Cardiac muscle contraction, Chemical carcinogenesis, Dilated cardiomyopathy, GABAergic synapse, Human cytomegalovirus infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MAPK signaling pathway, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, Synaptic vesicle cycle, TNF signaling pathway, VEGF signaling pathway |
070 [1] 70 💬 |
627 |
Multi-modal pain management [valium + gabapentin] |
Gabapentin |
[1] D00332 D00332 💬 |
CACNA2D1 [5] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [9] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle |
070 [1] 70 💬 |
628 |
Mupirocin |
Mupirocin |
[2] D01076 D01076, D02195 D02195 💬 |
- |
- |
227 [2] 227, 299 💬 |
629 |
Mupirocin intranasal creme |
Mupirocin |
[2] D01076 D01076, D02195 D02195 💬 |
- |
- |
299 [1] 299 💬 |
630 |
Mussel oil capsules |
- |
- |
- |
- |
046 [1] 46 💬 |
631 |
N-(5-hydroxy-2,4- bis(trimethylsilyl)phenyl)-4-oxo- 1,4-dihydroquinoline-3-carboxamide |
- |
- |
- |
- |
299 [1] 299 💬 |
632 |
N-(5-hydroxy-2,4-bis(trimethylsilyl)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide |
- |
- |
- |
- |
299 [1] 299 💬 |
633 |
N-(5-{4-[(3,3-dimethyl-1-azetidinyl)carbonyl]phenyl}[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide |
- |
- |
- |
- |
049 [1] 49 💬 |
634 |
N-(trans-3-(5-((r)-1-hydroxyethyl)-1,3,4-oxadiazol-2-yl)cyclobutyl)-3-phenylisoxazole-5-carboxamide |
- |
- |
- |
- |
299 [1] 299 💬 |
635 |
N-acetylcysteine capsule |
Acetylcysteine |
[1] D00221 D00221 💬 |
- |
- |
006 [1] 6 💬 |
636 |
N-carbamylglutamate |
Carglumic acid |
[1] D07130 D07130 💬 |
CPS1 [1] CPS1 💬 |
Alanine, aspartate and glutamate metabolism [6] Alanine, aspartate and glutamate metabolism, Arginine biosynthesis, Biosynthesis of amino acids, Carbon metabolism, Metabolic pathways, Nitrogen metabolism |
245 [2] 245, 246 💬 |
637 |
N-{4-chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamide, sodium |
- |
- |
- |
- |
096 [1] 96 💬 |
638 |
N-{4-chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamidesodium |
- |
- |
- |
- |
096 [1] 96 💬 |
639 |
Nacom levodopa+cardidopa |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [1] 6 💬 |
640 |
Nasal aztreonam |
Aztreonam |
[2] D00240 D00240, D06558 D06558 💬 |
- |
- |
299 [1] 299 💬 |
641 |
Nd0612 (levodopa/carbidopa solution) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
642 |
Neoral soft gelatin capsules |
Gelatin |
[2] D00115 D00115, D06892 D06892 💬 |
- |
- |
097 [2] 97, 269 💬 |
643 |
Neurontin 300 mg hard capsule |
- |
- |
- |
- |
013 [1] 13 💬 |
644 |
Nicardipine |
Nicardipine |
[2] D00617 D00617, D08270 D08270 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
070 [2] 70, 86 💬 |
645 |
Nilotinib 150mg oral capsule [tasigna] |
Nilotinib |
[1] D08953 D08953 💬 |
ABL1 [4] ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia [32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 [1] 6 💬 |
646 |
Nilotinib 300mg oral capsule [tasigna] |
Nilotinib |
[1] D08953 D08953 💬 |
ABL1 [4] ABL1, KIT, PDGFRA, PDGFRB 💬 |
Acute myeloid leukemia [32] Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis |
006 [1] 6 💬 |
647 |
Nnc0195-0092 dp 6.7 mg ml 3 ml cartridge |
- |
- |
- |
- |
078 [1] 78 💬 |
648 |
Novorapid 100 u/ml, solution for injection in a vial. novorapid penfill 100 u/ml, solution for injection in a cartridge. novorapid flexpen 100 u/ml, solution for injection in a pre-filled pen. |
- |
- |
- |
- |
299 [1] 299 💬 |
649 |
Odm-101 105mg carbidopa |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
650 |
Odm-101 65mg carbidopa |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
651 |
Odm-109 capsule 1 mg |
- |
- |
- |
- |
002 [1] 2 💬 |
652 |
Ofev 100 mg capsule |
- |
- |
- |
- |
085 [1] 85 💬 |
653 |
Ofev 150 mg capsule |
- |
- |
- |
- |
085 [1] 85 💬 |
654 |
Omaveloxolone capsules, 10 mg |
Omaveloxolone |
[1] D10964 D10964 💬 |
NFE2L2 [1] NFE2L2 💬 |
Fluid shear stress and atherosclerosis [5] Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 [1] 18 💬 |
655 |
Omaveloxolone capsules, 150 mg |
Omaveloxolone |
[1] D10964 D10964 💬 |
NFE2L2 [1] NFE2L2 💬 |
Fluid shear stress and atherosclerosis [5] Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 [1] 18 💬 |
656 |
Omaveloxolone capsules, 160 mg |
Omaveloxolone |
[1] D10964 D10964 💬 |
NFE2L2 [1] NFE2L2 💬 |
Fluid shear stress and atherosclerosis [5] Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 [1] 18 💬 |
657 |
Omaveloxolone capsules, 2.5 mg |
Omaveloxolone |
[1] D10964 D10964 💬 |
NFE2L2 [1] NFE2L2 💬 |
Fluid shear stress and atherosclerosis [5] Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 [1] 18 💬 |
658 |
Omaveloxolone capsules, 20 mg |
Omaveloxolone |
[1] D10964 D10964 💬 |
NFE2L2 [1] NFE2L2 💬 |
Fluid shear stress and atherosclerosis [5] Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 [1] 18 💬 |
659 |
Omaveloxolone capsules, 300 mg |
Omaveloxolone |
[1] D10964 D10964 💬 |
NFE2L2 [1] NFE2L2 💬 |
Fluid shear stress and atherosclerosis [5] Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 [1] 18 💬 |
660 |
Omaveloxolone capsules, 40 mg |
Omaveloxolone |
[1] D10964 D10964 💬 |
NFE2L2 [1] NFE2L2 💬 |
Fluid shear stress and atherosclerosis [5] Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 [1] 18 💬 |
661 |
Omaveloxolone capsules, 5 mg |
Omaveloxolone |
[1] D10964 D10964 💬 |
NFE2L2 [1] NFE2L2 💬 |
Fluid shear stress and atherosclerosis [5] Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 [1] 18 💬 |
662 |
Omaveloxolone capsules, 80 mg |
Omaveloxolone |
[1] D10964 D10964 💬 |
NFE2L2 [1] NFE2L2 💬 |
Fluid shear stress and atherosclerosis [5] Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum |
018 [1] 18 💬 |
663 |
Omeprazole 40mg capsule |
Omeprazole |
[4] D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A [2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
299 [1] 299 💬 |
664 |
Oral aztreonam |
Aztreonam |
[2] D00240 D00240, D06558 D06558 💬 |
- |
- |
299 [1] 299 💬 |
665 |
Oral levodopa and carbidopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
666 |
Oral levodopa/carbidopa |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
667 |
Oral scio-469 capsule |
- |
- |
- |
- |
046 [1] 46 💬 |
668 |
Other: caffeine |
Caffeine |
[2] D00528 D00528, D01453 D01453 💬 |
ADORA1 [11] ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism [22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
669 |
Other: calcium stable isotope |
Calcium |
- |
- |
- |
186 [1] 186 💬 |
670 |
Other: carbon monoxide-bubbled mediums |
Activated charcoal |
[2] D03251 D03251, D09706 D09706 💬 |
- |
- |
298 [1] 298 💬 |
671 |
Other: carboxy methyl cellulose |
Methylcellulose |
[2] D00093 D00093, D04996 D04996 💬 |
- |
- |
053 [1] 53 💬 |
672 |
Other: cardiopulmonary evaluation |
- |
- |
- |
- |
013 [1] 13 💬 |
673 |
Other: cawthorne cooksey exercises |
- |
- |
- |
- |
013 [1] 13 💬 |
674 |
Other: challenge agent: capsaicin |
Capsaicin |
[1] D00250 D00250 💬 |
TRPV1 [1] TRPV1 💬 |
Inflammatory mediator regulation of TRP channels [2] Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
019 [1] 19 💬 |
675 |
Other: data capture |
Bifenthrin |
- |
- |
- |
006 [1] 6 💬 |
676 |
Other: determination of calcium intake by a dietician interview |
Calcium |
- |
- |
- |
013 [2] 13, 46 💬 |
677 |
Other: dietary intervention with no-carrageenan diet |
- |
- |
- |
- |
097 [1] 97 💬 |
678 |
Other: empiric use of calcium carbonate and calcitriol |
Calcitriol |
[3] D00129 D00129, D00932 D00932, D10802 D10802 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
235 [1] 235 💬 |
679 |
Other: exercise capacity |
- |
- |
- |
- |
299 [1] 299 💬 |
680 |
Other: green tea (camellia sinensis) |
Green tea leaf |
[1] D06903 D06903 💬 |
- |
- |
096 [1] 96 💬 |
681 |
Other: ibuprofen and isosorbide dinitrate combination |
Ibuprofen |
[6] D00126 D00126, D00347 D00347, D00516 D00516, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
113 [1] 113 💬 |
682 |
Other: intensive supportive care |
- |
- |
- |
- |
066 [1] 66 💬 |
683 |
Other: liquid meal test (carbohydrate-rich) |
- |
- |
- |
- |
299 [1] 299 💬 |
684 |
Other: medication compliance phone call |
- |
- |
- |
- |
098 [1] 98 💬 |
685 |
Other: mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
686 |
Other: no doxycycline |
Doxycycline |
[5] D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
299 [1] 299 💬 |
687 |
Other: no intervention: standard of care |
- |
- |
- |
- |
085 [1] 85 💬 |
688 |
Other: optimized supportive care |
- |
- |
- |
- |
066 [1] 66 💬 |
689 |
Other: palliative care |
- |
- |
- |
- |
019 [5] 19, 65, 120, 160, 326 💬 |
690 |
Other: pth based calcium carbonate and calcitriol repletion |
Calcitriol |
[3] D00129 D00129, D00932 D00932, D10802 D10802 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
235 [1] 235 💬 |
691 |
Other: real-time data capture app |
Bifenthrin |
- |
- |
- |
046 [1] 46 💬 |
692 |
Other: serum calcium concentrations results |
Calcium |
- |
- |
- |
235 [1] 235 💬 |
693 |
Other: standard care |
- |
- |
- |
- |
227 [1] 227 💬 |
694 |
Other: standard of care |
- |
- |
- |
- |
013 [7] 13, 49, 64, 85, 96, 245, 246 💬 |
695 |
Other: standard of care (soc) |
- |
- |
- |
- |
062 [1] 62 💬 |
696 |
Other: standard of care sildenafil |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
090 [2] 90, 301 💬 |
697 |
Other: standard-of-care |
- |
- |
- |
- |
086 [1] 86 💬 |
698 |
Other: usual care |
- |
- |
- |
- |
046 [1] 46 💬 |
699 |
Other: usual care arm exercise |
- |
- |
- |
- |
006 [1] 6 💬 |
700 |
Overencapsulated mesalazine tablets |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
701 |
Pancrelipase delayed release capsule |
Pancrelipase |
[1] D05349 D05349 💬 |
- |
- |
298 [2] 298, 299 💬 |
702 |
Pasireotide with or without cabergoline |
Cabergoline |
[2] D00987 D00987, D10147 D10147 💬 |
DRD2 [6] DRD2, PRL, SSTR1, SSTR2, SSTR3, SSTR5 💬 |
Alcoholism [14] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway |
075 [1] 75 💬 |
703 |
Patient current care |
- |
- |
- |
- |
046 [1] 46 💬 |
704 |
Pemine - 150 mg capsule rigide 50 capsule |
- |
- |
- |
- |
171 [1] 171 💬 |
705 |
Physician standard-of-care |
- |
- |
- |
- |
096 [1] 96 💬 |
706 |
Pilocarpine |
Pilocarpine |
[3] D00525 D00525, D02200 D02200, D05478 D05478 💬 |
CHRM2 [2] CHRM2, CHRM3 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
006 [3] 6 , 53, 299 💬 |
707 |
Pilocarpine hydrochloride |
Pilocarpine |
[3] D00525 D00525, D02200 D02200, D05478 D05478 💬 |
CHRM2 [2] CHRM2, CHRM3 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
053 [1] 53 💬 |
708 |
Pilocarpine nitrate 5% |
Nitrate |
[4] D00525 D00525, D02200 D02200, D02313 D02313, D05478 D05478 💬 |
CHRM2 [2] CHRM2, CHRM3 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
299 [1] 299 💬 |
709 |
Piperazine |
Piperazine |
[6] D00807 D00807, D01393 D01393, D02127 D02127, D02145 D02145, D05486 D05486, D06224 D06224 💬 |
- |
- |
058 [1] 58 💬 |
710 |
Pitavastatin |
Pitavastatin |
[1] D01862 D01862 💬 |
- |
- |
049 [1] 49 💬 |
711 |
Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) conjugated to crm197 carrier protein and adsorbed on aluminium phosphate |
Aluminium |
- |
- |
- |
046 [1] 46 💬 |
712 |
Poly(oxy-1,2-ethanediyl), alpha-hydro-omega-methoxy, ether with n-[[[2-[[6-[[1-[3-[[3-(2,3-dihydroxypropoxy)propyl]amino]-3-oxopropyl]-2,5-dioxo-3-pyrrolidinyl]thio]hexyl]amino]ethyl]amino]carbonyl]-2-methylalanyl-teriparatide (2:1) |
Diethyl ether |
[2] D01772 D01772, D06078 D06078 💬 |
PTH1R [1] PTH1R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 [1] 235 💬 |
713 |
Positron emission tomography using [11 carbon]-3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile ([11c]-dasb) and [18 fluorine]-altanserin ([18f]-altanserin) |
Activated charcoal |
[1] D03251 D03251 💬 |
- |
- |
006 [1] 6 💬 |
714 |
Prednisone capsules |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
041 [1] 41 💬 |
715 |
Pregabalin |
Pregabalin |
[1] D02716 D02716 💬 |
CACNA2D1 [4] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 |
Adrenergic signaling in cardiomyocytes [7] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway |
013 [5] 13, 36, 46, 70, 298 💬 |
716 |
Pregabalin 75mg |
Pregabalin |
[1] D02716 D02716 💬 |
CACNA2D1 [4] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4 💬 |
Adrenergic signaling in cardiomyocytes [7] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway |
070 [1] 70 💬 |
717 |
Probiotic capsule |
- |
- |
- |
- |
006 [1] 6 💬 |
718 |
Probiotic capsules containing lactobacillus rhamnosus gr-1 and l. reuteri rc-14 |
- |
- |
- |
- |
046 [1] 46 💬 |
719 |
Probiotic formula capsule |
- |
- |
- |
- |
097 [1] 97 💬 |
720 |
Probiotic product - cap |
- |
- |
- |
- |
053 [1] 53 💬 |
721 |
Procedure: apheresis catheter placement |
- |
- |
- |
- |
096 [1] 96 💬 |
722 |
Procedure: arginine and clonidine stimulation testing |
Arginine |
[3] D00281 D00281, D00604 D00604, D02982 D02982 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
078 [1] 78 💬 |
723 |
Procedure: cardiac monitoring |
- |
- |
- |
- |
006 [1] 6 💬 |
724 |
Procedure: carotid ultrasound |
- |
- |
- |
- |
078 [1] 78 💬 |
725 |
Procedure: indirect calorimetry |
- |
- |
- |
- |
299 [1] 299 💬 |
726 |
Procedure: intravenous catheter |
- |
- |
- |
- |
231 [1] 231 💬 |
727 |
Procedure: pilocarpine |
Pilocarpine |
[3] D00525 D00525, D02200 D02200, D05478 D05478 💬 |
CHRM2 [2] CHRM2, CHRM3 💬 |
Alzheimer disease [13] Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway |
053 [1] 53 💬 |
728 |
Procedure: rf catheter ablation |
- |
- |
- |
- |
058 [1] 58 💬 |
729 |
Procedure: use of an electronic data capture system by patients and physicians to assess patient-physician interactions & therapeutic decisions & outcomes in ra subjects. |
Bifenthrin |
- |
- |
- |
046 [1] 46 💬 |
730 |
Prograft capsules |
- |
- |
- |
- |
299 [1] 299 💬 |
731 |
Propionyl l-carnitine |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
097 [1] 97 💬 |
732 |
Propionyl l-carnitine hydrochloride |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
097 [1] 97 💬 |
733 |
Propionyl-l-carnitine |
Levocarnitine |
[3] D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
097 [1] 97 💬 |
734 |
Protein-carbohydrate supplementation |
- |
- |
- |
- |
113 [1] 113 💬 |
735 |
Prototype capsule gdc-0134 |
- |
- |
- |
- |
002 [1] 2 💬 |
736 |
Quinidine |
Quinidine |
[4] D00642 D00642, D00643 D00643, D02272 D02272, D08458 D08458 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
002 [3] 2 , 8 , 13 💬 |
737 |
Quinidine sulfate |
Quinidine |
[4] D00642 D00642, D00643 D00643, D02272 D02272, D08458 D08458 💬 |
SCN1A [5] SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
013 [1] 13 💬 |
738 |
Qutenza (8% capsaicin) |
Capsaicin |
[1] D00250 D00250 💬 |
TRPV1 [1] TRPV1 💬 |
Inflammatory mediator regulation of TRP channels [2] Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
086 [1] 86 💬 |
739 |
Radiation: cardiac pet imaging using f-18-fdg, n-13 ammonia( nh3) |
Ammonia |
[1] D02916 D02916 💬 |
- |
- |
088 [1] 88 💬 |
740 |
Radiation: computed tomography lung subtraction iodine mapping |
Iodine |
[1] D00108 D00108 💬 |
- |
- |
088 [1] 88 💬 |
741 |
Rapamycin-calcitriol combination |
Calcitriol |
[2] D00129 D00129, D00753 D00753 💬 |
MTOR [2] MTOR, VDR 💬 |
AMPK signaling pathway [54] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Mineral absorption, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Tuberculosis, Type II diabetes mellitus, mTOR signaling pathway |
158 [1] 158 💬 |
742 |
Rasagiline 1 mg capsule |
Rasagiline |
[3] D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
743 |
Rebif new formulation + ibuprofen prn |
Ibuprofen |
[4] D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
744 |
Rebif new formulation + prophylactic ibuprofen |
Ibuprofen |
[4] D00126 D00126, D01122 D01122, D04490 D04490, D06606 D06606 💬 |
PTGS1 [2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [1] 13 💬 |
745 |
Rebif new formulation 44mcg multidose cartridge |
- |
- |
- |
- |
013 [1] 13 💬 |
746 |
Reference capsule gdc-0134 |
- |
- |
- |
- |
002 [1] 2 💬 |
747 |
Reminder capsules |
- |
- |
- |
- |
019 [1] 19 💬 |
748 |
Repatha 420 mg solution for injection in cartridge |
- |
- |
- |
- |
079 [1] 79 💬 |
749 |
Retrospective case only |
- |
- |
- |
- |
172 [1] 172 💬 |
750 |
Rhudex 100 mg (127 mg rhudex choline salt) granules |
Choline |
[1] D07690 D07690 💬 |
- |
- |
093 [1] 93 💬 |
751 |
Rhudex 25 mg (31.75 mg rhudex choline salt) granules |
Choline |
[1] D07690 D07690 💬 |
- |
- |
093 [1] 93 💬 |
752 |
Rhudex 50 mg (63.5 mg rhudex choline salt) granules |
Choline |
[1] D07690 D07690 💬 |
- |
- |
093 [1] 93 💬 |
753 |
Rhudex choline salt |
Choline |
[1] D07690 D07690 💬 |
- |
- |
093 [1] 93 💬 |
754 |
Rigosertib oral capsules / rigosertib intravenous |
Rigosertib |
[1] D10154 D10154 💬 |
PLK1 [1] PLK1 💬 |
Cell cycle [4] Cell cycle, FoxO signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation |
036 [1] 36 💬 |
755 |
Ritalin la 20mg capsules |
- |
- |
- |
- |
013 [1] 13 💬 |
756 |
Ritalin la 30mg capsules |
- |
- |
- |
- |
013 [1] 13 💬 |
757 |
Ritalin la 40mg capsules |
- |
- |
- |
- |
013 [1] 13 💬 |
758 |
Rituxan (us, canada, japan), mabthera (rest of the world) |
- |
- |
- |
- |
046 [1] 46 💬 |
759 |
Rituxan (us, canada, japan), mabthera (rest of world) |
- |
- |
- |
- |
053 [1] 53 💬 |
760 |
Rivastigmine capsule |
Rivastigmine |
[2] D02558 D02558, D03822 D03822 💬 |
ACHE [1] ACHE 💬 |
Cholinergic synapse [2] Cholinergic synapse, Glycerophospholipid metabolism |
006 [1] 6 💬 |
761 |
Rob 803 (capsules 12.5 mg) |
- |
- |
- |
- |
046 [1] 46 💬 |
762 |
Rob 803 (capsules 15 mg) |
- |
- |
- |
- |
046 [1] 46 💬 |
763 |
Rob 803 (capsules 25 mg) |
- |
- |
- |
- |
046 [1] 46 💬 |
764 |
Rob 803 (capsules 6.25 mg) |
- |
- |
- |
- |
046 [1] 46 💬 |
765 |
Rob 803 12.5mg capsule |
- |
- |
- |
- |
046 [1] 46 💬 |
766 |
Rob 803 15mg capsule |
- |
- |
- |
- |
046 [1] 46 💬 |
767 |
Rob 803 25mg capsule |
- |
- |
- |
- |
046 [1] 46 💬 |
768 |
Rob 803 6.25mg capsule |
- |
- |
- |
- |
046 [1] 46 💬 |
769 |
Rob 803 6.5mg capsule |
- |
- |
- |
- |
046 [1] 46 💬 |
770 |
Rosuvastatin |
Rosuvastatin |
[2] D01915 D01915, D08492 D08492 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 [11] 6 , 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬 |
771 |
Rosuvastatin 10 mg |
Rosuvastatin |
[2] D01915 D01915, D08492 D08492 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
096 [1] 96 💬 |
772 |
Rosuvastatin 20mg |
Rosuvastatin |
[2] D01915 D01915, D08492 D08492 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
079 [1] 79 💬 |
773 |
Rosuvastatin calcium |
Calcium |
[2] D01915 D01915, D08492 D08492 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
049 [4] 49, 79, 97, 299 💬 |
774 |
Rosuvastatin calcium 40mg |
Calcium |
[2] D01915 D01915, D08492 D08492 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
056 [1] 56 💬 |
775 |
Rwj-445380 capsule 100 mg |
- |
- |
- |
- |
046 [1] 46 💬 |
776 |
Rwj-445380 capsules 150 mg |
- |
- |
- |
- |
046 [1] 46 💬 |
777 |
Rwj-445380 capsules 50 mg |
- |
- |
- |
- |
046 [1] 46 💬 |
778 |
S-adenosyl-methionine (same) capsules |
Ademetionine |
[3] D00019 D00019, D04983 D04983, D07128 D07128 💬 |
- |
- |
093 [1] 93 💬 |
779 |
Sarcosine capsule |
Sarcosine |
- |
- |
- |
006 [1] 6 💬 |
780 |
Seasonal influenza vaccine available for the 2012-2013 vaccine campaign |
- |
- |
- |
- |
084 [1] 84 💬 |
781 |
Seladelpar 10 mg capsule |
- |
- |
- |
- |
093 [1] 93 💬 |
782 |
Seladelpar 5 mg capsule |
- |
- |
- |
- |
093 [1] 93 💬 |
783 |
Sevelamer |
Sevelamer |
[3] D01983 D01983, D06642 D06642, D08512 D08512 💬 |
- |
- |
235 [1] 235 💬 |
784 |
Sildenafil 40mg oral capsule |
Sildenafil |
[2] D02229 D02229, D08514 D08514 💬 |
PDE5A [1] PDE5A 💬 |
Metabolic pathways [3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway |
299 [1] 299 💬 |
785 |
Sinemet (carbidopa/levodopa) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
786 |
Sinemet (levodopa/carbidopa) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
787 |
Sinemet plus (levodopa/carbidopa) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
788 |
Sinemet® controlled release (carbidopa/levodopa) |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
789 |
Site specific standard of care comparison |
- |
- |
- |
- |
038 [2] 38, 39 💬 |
790 |
Ski-o-703 capsule |
- |
- |
- |
- |
046 [1] 46 💬 |
791 |
Smoked cannabis |
Medical Cannabis |
- |
- |
- |
013 [1] 13 💬 |
792 |
Smoking of cannabis |
Medical Cannabis |
- |
- |
- |
096 [2] 96, 97 💬 |
793 |
Sodium (r)-8-methyl-2-(3-methylbenzofuran-2-yl)-5-(1-(tetrahydro-2h-pyran-4-yl)ethoxy)quinoline-4-ca |
- |
- |
- |
- |
299 [1] 299 💬 |
794 |
Solu medrol - 125 mg/2 ml polvere e solvente per soluzione iniettabile 1 flacone a doppia camera da 125 mg/2 ml |
- |
- |
- |
- |
013 [3] 13, 14, 53 💬 |
795 |
Soluble ve cadherin |
- |
- |
- |
- |
051 [1] 51 💬 |
796 |
Spd476 (mesalazine) |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
797 |
Spd476 is a polymeric matrix formulation that displays both delayed- and extended-release of mesalazine |
Mesalazine |
[1] D00377 D00377 💬 |
- |
- |
097 [1] 97 💬 |
798 |
Spi-1005 ebselen 200mg capsule x1 |
Ebselen |
- |
- |
- |
299 [1] 299 💬 |
799 |
Spi-1005 ebselen 200mg capsule x2 |
Ebselen |
- |
- |
- |
299 [1] 299 💬 |
800 |
Spi-1005 ebselen 200mg capsule x3 |
Ebselen |
- |
- |
- |
299 [1] 299 💬 |
801 |
Spironolactone |
Spironolactone |
[1] D00443 D00443 💬 |
NR3C2 [1] NR3C2 💬 |
Aldosterone-regulated sodium reabsorption [1] Aldosterone-regulated sodium reabsorption |
058 [7] 58, 67, 86, 113, 210, 218, 225 💬 |
802 |
Spironolactone (drug) |
Spironolactone |
[1] D00443 D00443 💬 |
NR3C2 [1] NR3C2 💬 |
Aldosterone-regulated sodium reabsorption [1] Aldosterone-regulated sodium reabsorption |
210 [1] 210 💬 |
803 |
Spironolactone and conivaptan |
Conivaptan |
[3] D00443 D00443, D01236 D01236, D07748 D07748 💬 |
AVPR1A [3] AVPR1A, AVPR2, NR3C2 💬 |
Aldosterone-regulated sodium reabsorption [6] Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vascular smooth muscle contraction, Vasopressin-regulated water reabsorption |
086 [1] 86 💬 |
804 |
Spironolactone captopril carvedilol |
Captopril |
[4] D00251 D00251, D00255 D00255, D00443 D00443, D03415 D03415 💬 |
ACE [7] ACE, ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2, NR3C2 💬 |
AMPK signaling pathway [18] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone-regulated sodium reabsorption, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Hypertrophic cardiomyopathy, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
086 [1] 86 💬 |
805 |
Ssp-004184 100 mg capsule |
- |
- |
- |
- |
284 [1] 284 💬 |
806 |
Ssp-004184 250 mg capsule |
- |
- |
- |
- |
284 [1] 284 💬 |
807 |
Ssp-004184 375 mg capsule |
- |
- |
- |
- |
284 [1] 284 💬 |
808 |
Ssp-004184 50 mg capsule |
- |
- |
- |
- |
284 [1] 284 💬 |
809 |
Ssp-004184 500 mg capsule |
- |
- |
- |
- |
284 [1] 284 💬 |
810 |
Ssp-004184aq 100 mg capsule |
- |
- |
- |
- |
284 [1] 284 💬 |
811 |
Ssp-004184aq 200 mg capsule |
- |
- |
- |
- |
284 [1] 284 💬 |
812 |
Ssp-004184aq 250 mg capsule |
- |
- |
- |
- |
284 [1] 284 💬 |
813 |
Ssp-004184aq 375 mg capsule |
- |
- |
- |
- |
284 [1] 284 💬 |
814 |
Ssp-004184aq 50 mg capsule |
- |
- |
- |
- |
284 [1] 284 💬 |
815 |
Stalevo (levodopa/ carbidopa/ entacapone) |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
816 |
Stalevo (levodopa/carbidopa/entacapona) |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
817 |
Stalevo (levodopa/carbidopa/entacapone) |
Carbidopa |
[3] D00059 D00059, D00558 D00558, D00781 D00781 💬 |
COMT [7] COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
818 |
Standard care |
- |
- |
- |
- |
081 [2] 81, 299 💬 |
819 |
Standard care hyaluronic acid eye drops |
Hyaluronic acid |
[1] D08043 D08043 💬 |
- |
- |
053 [1] 53 💬 |
820 |
Standard of care |
- |
- |
- |
- |
006 [12] 6 , 13, 14, 46, 49, 51, 63, 64, 79, 85, 158, 271 💬 |
821 |
Standard of care for haemophilia a |
- |
- |
- |
- |
288 [1] 288 💬 |
822 |
Standard of care fviii replacement therapy |
- |
- |
- |
- |
288 [1] 288 💬 |
823 |
Standard of care iv antibiotic(s) |
- |
- |
- |
- |
299 [1] 299 💬 |
824 |
Standard of care medications |
- |
- |
- |
- |
171 [1] 171 💬 |
825 |
Standard of care therapy |
- |
- |
- |
- |
028 [1] 28 💬 |
826 |
Standard of care treatment |
- |
- |
- |
- |
245 [2] 245, 246 💬 |
827 |
Standard step-up care |
- |
- |
- |
- |
096 [1] 96 💬 |
828 |
Standardized cannabis extract |
Medical Cannabis |
- |
- |
- |
013 [1] 13 💬 |
829 |
Standrd of care treatment |
- |
- |
- |
- |
064 [1] 64 💬 |
830 |
Sucralfate |
Sucralfate |
[1] D00446 D00446 💬 |
- |
- |
098 [1] 98 💬 |
831 |
Symptomatic treatment (converting enzyme inhibitor, angiotensin ii, anti-renin, aldosterone antagonist diuretic, beta blocker, calcium inhibitor, statin) |
Aldosterone |
[3] D00150 D00150, D02014 D02014, D10528 D10528 💬 |
AGTR1 [3] AGTR1, AGTR2, NR3C2 💬 |
AGE-RAGE signaling pathway in diabetic complications [17] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Aldosterone-regulated sodium reabsorption, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
222 [1] 222 💬 |
832 |
Tacrolimus capsule |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
011 [1] 11 💬 |
833 |
Tacrolimus capsule (low-dose) |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
227 [1] 227 💬 |
834 |
Tacrolimus capsules |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
222 [2] 222, 299 💬 |
835 |
Tacrolimus prolonged-release hard capsules |
Tacrolimus |
[2] D00107 D00107, D08556 D08556 💬 |
PPP3CA [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease [32] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
299 [1] 299 💬 |
836 |
Tafamidis meglumine 20 mg soft gelatin capsules |
Gelatin |
[4] D00115 D00115, D01796 D01796, D06892 D06892, D09673 D09673 💬 |
TTR [1] TTR 💬 |
Thyroid hormone synthesis [1] Thyroid hormone synthesis |
028 [1] 28 💬 |
837 |
Tafamidis meglumine 20mg soft gelatin capsule (clinical trial image) |
Gelatin |
[4] D00115 D00115, D01796 D01796, D06892 D06892, D09673 D09673 💬 |
TTR [1] TTR 💬 |
Thyroid hormone synthesis [1] Thyroid hormone synthesis |
028 [1] 28 💬 |
838 |
Tafamidis meglumine 20mg soft gelatin capsule (commerical image) |
Gelatin |
[4] D00115 D00115, D01796 D01796, D06892 D06892, D09673 D09673 💬 |
TTR [1] TTR 💬 |
Thyroid hormone synthesis [1] Thyroid hormone synthesis |
028 [1] 28 💬 |
839 |
Tauroursodeoxycholic acid capsules |
Tauroursodeoxycholic acid |
[1] D11836 D11836 💬 |
- |
- |
093 [1] 93 💬 |
840 |
Teriflunomide capsule |
Teriflunomide |
[1] D10172 D10172 💬 |
DHODH [1] DHODH 💬 |
Biosynthesis of cofactors [3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism |
013 [1] 13 💬 |
841 |
Teriparatide conjugated to a multiarm polyethylene glycol carrier molecule through a cleavable linker |
Polyethylene glycol |
[2] D03370 D03370, D06078 D06078 💬 |
PTH1R [1] PTH1R 💬 |
Endocrine and other factor-regulated calcium reabsorption [3] Endocrine and other factor-regulated calcium reabsorption, Neuroactive ligand-receptor interaction, Parathyroid hormone synthesis, secretion and action |
235 [1] 235 💬 |
842 |
Thalidomide celgene - 50 mg capsula rigida - uso orale - blister (pvc/pe/aclar/alu) 28 capsule |
Thalidomide |
[1] D00754 D00754 💬 |
TNF [1] TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications [65] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 [1] 96 💬 |
843 |
The pop02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: |
- |
- |
- |
- |
086 [1] 86 💬 |
844 |
The pops study is collecting pk data on children prescribed the following drugs of interest per standard of care: |
- |
- |
- |
- |
086 [1] 86 💬 |
845 |
Tizanidine hydrochloride capsule |
Tizanidine |
[2] D00776 D00776, D08611 D08611 💬 |
ADRA2A [3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
013 [1] 13 💬 |
846 |
Tobi podhaler - 28 mg polvere per inalazione capsula rigida uso inalatorio blister(alu/alu) 56 capsule + 1 inalatore |
- |
- |
- |
- |
299 [1] 299 💬 |
847 |
Topical calcipotriene 0.005% ointment |
Calcipotriol |
[1] D01125 D01125 💬 |
VDR [1] VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption [4] Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
051 [1] 51 💬 |
848 |
Total glucosides paeony capsules |
- |
- |
- |
- |
271 [1] 271 💬 |
849 |
Transdermal fentanyl matrix, gabapentin |
Fentanyl |
[3] D00320 D00320, D00332 D00332, D01399 D01399 💬 |
CACNA2D1 [6] CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, OPRM1, SLC6A1 💬 |
Adrenergic signaling in cardiomyocytes [12] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Estrogen signaling pathway, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, Synaptic vesicle cycle |
070 [1] 70 💬 |
850 |
Transplant conditioning with mobilization and alemtuzumab |
Alemtuzumab |
[1] D02802 D02802 💬 |
- |
- |
065 [1] 65 💬 |
851 |
Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan |
Alemtuzumab |
[5] D00369 D00369, D00583 D00583, D01907 D01907, D02802 D02802, D07966 D07966 💬 |
RRM1 [1] RRM1 💬 |
Drug metabolism - other enzymes [5] Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
065 [2] 65, 164 💬 |
852 |
Treatment with systemic therapy (doxycycline) |
Doxycycline |
[5] D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
162 [1] 162 💬 |
853 |
Trientine dihydrochloride 300mg capsules |
Triethylenetetramine |
- |
- |
- |
171 [1] 171 💬 |
854 |
Trimethaphan |
Trimethaphan |
[1] D00612 D00612 💬 |
CHRNA10 [1] CHRNA10 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
017 [1] 17 💬 |
855 |
Ultra-high-caloric carbohydrate-rich diet |
- |
- |
- |
- |
002 [1] 2 💬 |
856 |
Ultra-high-caloric fatty diet |
- |
- |
- |
- |
002 [1] 2 💬 |
857 |
Untreated to atorvastatin treatment |
Atorvastatin |
[3] D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR [1] HMGCR 💬 |
AMPK signaling pathway [4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 [1] 13 💬 |
858 |
Urea |
Urea |
[2] D00023 D00023, D01749 D01749 💬 |
- |
- |
072 [2] 72, 251 💬 |
859 |
Ursodeoxycholic acid 300mg capsule |
Ursodeoxycholic acid |
[1] D00734 D00734 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
860 |
Ursodeoxycholic acid capsules |
Ursodeoxycholic acid |
[1] D00734 D00734 💬 |
NR1H4 [1] NR1H4 💬 |
Bile secretion [1] Bile secretion |
093 [1] 93 💬 |
861 |
Ursofalk® capsules |
- |
- |
- |
- |
093 [1] 93 💬 |
862 |
Usual current care |
- |
- |
- |
- |
096 [2] 96, 97 💬 |
863 |
Valproate, levocarnitine |
Levocarnitine |
[4] D00399 D00399, D02030 D02030, D02176 D02176, D04713 D04713 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 [1] 3 💬 |
864 |
Valproic acid and levocarnitine |
Levocarnitine |
[4] D00399 D00399, D02030 D02030, D02176 D02176, D04713 D04713 💬 |
ABAT [7] ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬 |
Alanine, aspartate and glutamate metabolism [17] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Metabolic pathways, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism |
003 [1] 3 💬 |
865 |
Verapamil |
Verapamil |
[2] D00619 D00619, D02356 D02356 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 [3] 96, 140, 167 💬 |
866 |
Verapamil sr |
Verapamil |
[2] D00619 D00619, D02356 D02356 💬 |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes [36] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
167 [1] 167 💬 |
867 |
Vibrox 100mg capsules |
- |
- |
- |
- |
167 [1] 167 💬 |
868 |
Vidofludimus calcium |
Calcium |
- |
- |
- |
013 [4] 13, 94, 96, 97 💬 |
869 |
Vidofludimus calcium dihydrate |
Calcium |
- |
- |
- |
097 [1] 97 💬 |
870 |
Vitamin: choline bitartrate (2-hydroxyethyl) trimethylammonium salt 1:1 |
Choline |
[1] D07690 D07690 💬 |
- |
- |
299 [1] 299 💬 |
871 |
Vyndaqel 20mg soft capsule |
- |
- |
- |
- |
028 [1] 28 💬 |
872 |
Wd-1603 carbidopa and levodopa extended-release tablets |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
873 |
Wd-1603 carbidopa/levodopa extended-release tablets |
Carbidopa |
[2] D00059 D00059, D00558 D00558 💬 |
DDC [6] DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway |
006 [1] 6 💬 |
874 |
Xinfeng capsule |
- |
- |
- |
- |
046 [1] 46 💬 |
875 |
Xp21279 and carbidopa (experimental) |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [1] 6 💬 |
876 |
Zonisamide capsules |
Zonisamide |
[1] D00538 D00538 💬 |
CACNA1G [8] CACNA1G, CACNA1H, CACNA1I, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes [11] Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus |
006 [1] 6 💬 |